Bioceres Crop Solutions (BIOX) 6-K 25 Feb 22 Current report (foreign) Financial data

Document and Entity Information

Document and Entity Information	6 Months Ended
	Dec. 31, 2021
Document and Entity Information [Abstract]
Document Type	6-K
Entity Registrant Name	Bioceres Crop Solutions Corp.
Entity Central Index Key	0001769484
Document Period End Date	Dec. 31, 2021
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Amendment Flag	false

UNAUDITED INTERIM CONDENSED CON

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($)	Dec. 31, 2021	Jun. 30, 2021
CURRENT ASSETS
Cash and cash equivalents	$ 36,366,131	$ 36,046,113
Other financial assets	3,607,639	11,161,398
Trade receivables	119,285,056	88,784,172
Other receivables	16,255,750	11,153,705
Income and minimum presumed recoverable income taxes	1,072,748	990,881
Inventories	87,308,712	61,037,551
Biological assets	8,142,920	2,315,838
Total current assets	272,038,956	211,489,658
NON-CURRENT ASSETS
Other financial assets	869,032	1,097,462
Trade receivables	121,234	135,739
Other receivables	1,810,645	2,543,142
Income and minimum presumed recoverable income taxes	31,112	12,589
Deferred tax assets	5,427,325	3,278,370
Investments in joint ventures and associates	34,054,957	30,657,173
Property, plant and equipment	48,946,555	47,954,596
Intangible assets	72,563,018	67,342,362
Goodwill	32,288,120	28,751,206
Right of use asset	1,488,608	1,327,660
Total non-current assets	197,600,606	183,100,299
Total assets	469,639,562	394,589,957
CURRENT LIABILITIES
Trade and other payables	106,016,242	72,091,408
Borrowings	48,230,663	76,785,857
Employee benefits and social security	6,472,078	4,680,078
Deferred revenue and advances from customers	7,110,046	6,277,313
Income tax payable	11,687,238	7,452,891
Lease liabilities	635,240	750,308
Total current liabilities	180,151,507	168,037,855
NON-CURRENT LIABILITIES
Borrowings	90,738,228	47,988,468
Government grants		784
Joint ventures and associates	616,173	1,278,250
Deferred tax liabilities	24,335,655	25,699,495
Provisions	484,490	449,847
Consideration for acquisition	12,443,071	11,790,533
Convertible notes	48,890,332	48,664,012
Lease liabilities	570,505	390,409
Total non-current liabilities	178,078,454	136,261,798
Total liabilities	358,229,961	304,299,653
EQUITY
Equity attributable to owners of the parent	84,156,819	67,743,242
Non-controlling interests	27,252,782	22,547,062
Total equity	111,409,601	90,290,304
Total equity and liabilities	$ 469,639,562	$ 394,589,957

UNAUDITED INTERIM CONDENSED C_2

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Revenues from contracts with customers	$ 92,313,776	$ 48,003,308	$ 158,667,650	$ 90,108,598
Government grants	337	556	805	1,160
Initial recognition and changes in the fair value of biological assets	1,590,925	734,826	2,142,828	984,193
Changes in the net realizable value of agricultural products after harvest	(1,242,185)		(1,242,185)
Total	92,662,853	48,738,690	159,569,098	91,093,951
Cost of sales	(55,332,989)	(25,073,842)	(93,215,442)	(48,186,484)
Research and development expenses	(1,384,032)	(1,114,820)	(2,815,574)	(2,139,032)
Selling, general and administrative expenses	(18,814,561)	(11,219,716)	(34,997,761)	(21,311,959)
Share of profit or loss of joint ventures and associates	1,141,323	65,975	919,087	305,687
Other income or expenses, net	(571,365)	135,132	(1,717,982)	140,322
Operating profit	17,701,229	11,531,419	27,741,426	19,902,485
Financial cost	(3,420,256)	(5,366,130)	(6,763,065)	(10,642,180)
Other financial results	(4,801,365)	(530,744)	(6,638,224)	(7,990,156)
Profit before income tax	9,479,608	5,634,545	14,340,137	1,270,149
Income tax	(4,141,102)	(3,835,587)	(6,736,415)	(5,841,453)
Profit (loss) for the period	5,338,506	1,798,958	7,603,722	(4,571,304)
Profit (loss) for the period attributable to:
Equity holders of the parent	3,427,093	648,193	4,301,230	(6,323,365)
Non-controlling interests	1,911,413	1,150,765	3,302,492	1,752,061
Profit (loss) for the period	$ 5,338,506	$ 1,798,958	$ 7,603,722	$ (4,571,304)
Profit (loss) per share
Basic profit (loss) attributable to ordinary equity holders of the parent	$ 0.0834	$ 0.0171	$ 0.1046	$ (0.1663)
Diluted profit (loss) attributable to ordinary equity holders of the parent	$ 0.0808	$ 0.0166	$ 0.1014	$ (0.1663)
Weighted average number of shares
Basic	41,104,331	38,016,601	41,104,331	38,016,601
Diluted	42,403,196	39,038,280	42,403,196	38,016,601
Other comprehensive income	$ 7,893,351	$ 658,996	$ 13,622,488	$ 795,127
Items that may be subsequently reclassified to profit and loss	9,331,728	898,436	16,449,749	912,232
Exchange differences on translation of foreign operations from joint ventures	1,887,130	126,434	3,504,622	49,996
Exchange differences on translation of foreign operations	7,444,598	772,002	12,945,127	862,236
Items that will not be subsequently reclassified to loss and profit	(1,438,377)	(239,440)	(2,827,261)	(117,105)
Revaluation of property, plant and equipment, net of tax, of joint ventures and associates	(189,996)	(25,630)	(363,848)	(11,495)
Revaluation of property, plant and equipment, net of tax	(1,248,381)	(213,810)	(2,463,413)	(105,610)
Total comprehensive profit (loss)	13,231,857	2,457,954	21,226,210	(3,776,177)
Total comprehensive profit (loss) attributable to:
Equity holders of the parent	10,074,002	1,244,596	15,796,061	(5,789,271)
Non-controlling interests	3,157,855	1,213,358	5,430,149	2,013,094
Total comprehensive profit (loss)	$ 13,231,857	$ 2,457,954	$ 21,226,210	$ (3,776,177)

UNAUDITED INTERIM CONDENSED C_3

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Income tax relating to changes in revaluation surplus included in other comprehensive income for joint venture and associates	$ 102,306	$ 880	$ 195,918	$ (3,832)
Income tax relating to changes in revaluation surplus included in other comprehensive income	$ 672,205	$ 863	$ 1,326,453	$ 35,204

UNAUDITED INTERIM CONDENSED C_4

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)	Equity / (deficit) attributable to owners of the parent	Issued capital	Share premium	Changes in non-controlling interest	Own shares trading premium	Stock options and share based incentives	Convertible instruments	Cost of own shares held	Retained deficit	Foreign currency translation reserve	Revaluation of PP&E and effect of tax rate change	Non-controlling Interests	Total
Beginning balance at Jun. 30, 2020	$ 46,179,395	$ 3,613	$ 96,486,865			$ 3,428,029	$ 702,981	$ (30,906)	$ (18,613,112)	$ (43,198,201)	$ 7,400,126	$ 14,570,087	$ 60,749,482
Capitalization of warrants	6,849,468	260	7,765,410		$ (916,202)								6,849,468
Shares issued	15,000,000	188	14,999,812										15,000,000
Share-based incentives	636,519					636,519							636,519
Purchase of own shares	(1,608,560)							(1,608,560)					(1,608,560)
Profit (loss) for the period	(6,323,365)								(6,323,365)			1,752,061	(4,571,304)
Other comprehensive income or loss	534,094									627,778	(93,684)	261,033	795,127
Ending balance at Dec. 31, 2020	61,267,551	4,061	119,252,087		(916,202)	4,064,548	702,981	(1,639,466)	(24,936,477)	(42,570,423)	7,306,442	16,583,181	77,850,732
Beginning balance at Jun. 30, 2021	67,743,242	4,158	120,662,386		(916,202)	3,672,768	702,981	(3,530,926)	(25,483,275)	(32,622,808)	5,254,160	22,547,062	90,290,304
Share-based incentives	873,409		20,205			853,204							873,409
Changes in non-controlling interests	(255,893)			$ (255,893)								(724,429)	(980,322)
Profit (loss) for the period	4,301,230								4,301,230			3,302,492	7,603,722
Other comprehensive income or loss	11,494,831									13,756,640	(2,261,809)	2,127,657	13,622,488
Ending balance at Dec. 31, 2021	$ 84,156,819	$ 4,158	$ 120,682,591	$ (255,893)	$ (916,202)	$ 4,525,972	$ 702,981	$ (3,530,926)	$ (21,182,045)	$ (18,866,168)	$ 2,992,351	$ 27,252,782	$ 111,409,601

UNAUDITED INTERIM CONDENSED C_5

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
OPERATING ACTIVITIES
Profit (loss) for the period	$ 7,603,722	$ (4,571,304)
Adjustments to reconcile profit to net cash flows
Income tax	6,736,415	5,841,453
Finance results	13,401,289	18,632,336
Depreciation of property, plant and equipment	1,668,788	1,104,537
Amortization of intangible assets	1,375,998	1,071,448
Depreciation of leased assets	501,232	287,484
Transactional expenses	0	1,839,679
Share-based incentive and stock options	873,407	636,519
Share of profit or loss of joint ventures and associates	(919,087)	(305,687)
Provisions for contingencies	65,598	52,441
Allowance for impairment of trade debtors	815,929	126,593
Allowance for obsolescence	740,264	365,458
Initial recognition and changes in the fair value of biological assets	(2,142,828)	(984,193)
Changes in the net realizable value of agricultural products after harvest	1,242,185
Gain or loss on sale of equipment and intangible assets	(133,586)	(7,919)
Working capital adjustments
Trade receivables	(34,516,244)	(25,172,336)
Other receivables	(4,827,685)	(3,457,049)
Income tax paid	6,742,149	4,560,265
Inventories and biological assets	(35,202,949)	(13,147,532)
Trade and other payables	31,932,303	3,252,321
Employee benefits and social security	1,604,112	(1,009,417)
Deferred revenue and advances from customers	745,423	(1,797,030)
Income and minimum presumed income taxes paid	(3,041,629)
Government grants	(784)	(1,650)
Interest collected	1,866,722	1,658,084
Inflation effects on working capital adjustments	(16,998,252)	(12,620,160)
Net cash flows used in operating activities	(19,867,508)	(23,645,659)
INVESTMENT ACTIVITIES
Proceeds from sale of property, plant and equipment	319,587	82,510
Acquisition of assets		(5,000,000)
Proceeds from financial assets	8,657,999
Investment in financial assets	(482,849)	(2,630,731)
Purchase of property, plant and equipment	(1,756,346)	(1,755,975)
Acquisition of investment property		(758,063)
Capitalized development expenditures	(2,425,244)	(1,556,367)
Purchase of intangible assets	(346,268)	(576,684)
Net cash flows generated (used in) by investing activities	3,966,879	(12,195,310)
FINANCING ACTIVITIES
Proceeds from borrowings	79,923,730	69,542,113
Repayment of borrowings, financed payments and interest payments	(58,787,312)	(55,374,045)
(Decrease) increase in bank overdrafts and other short-term borrowings	(32,838)	1,374,003
Other financial proceeds or payments, net	(2,107,971)	(435,635)
Acquisition of non-controlling interest in subsidiaries	(724,429)
Leased assets payments	(493,453)	(293,182)
Warrants tender offer payments		(1,030,952)
Purchase of own shares		(1,608,560)
Net cash flows generated by financing activities	17,777,727	12,173,742
Net increase (decrease) in cash and cash equivalents	1,877,098	(23,667,227)
Inflation effects on cash and cash equivalents	(3,592,117)	(1,655,143)
Cash and cash equivalents as of beginning of the period	36,046,113	42,522,861
Effect of exchange rate changes on cash and equivalents	2,035,037	1,929,715
Cash and cash equivalents as of the end of the period	$ 36,366,131	$ 19,130,206

GENERAL INFORMATION

GENERAL INFORMATION	6 Months Ended
	Dec. 31, 2021
GENERAL INFORMATION
GENERAL INFORMATION	1. GENERAL INFORMATION Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a fully integrated provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. To do this, Bioceres’ solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices. The Group has a unique biotech platform with high impact, patented technologies for seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions. Bioceres is a global company with an extensive geographic footprint. The Group’s agricultural inputs are marketed across more than 30 countries, mainly in Argentina, Brazil, United States,Europe and South Africa. Unless the context otherwise requires, “we”, “us”, “our”, “Bioceres”, “BIOX”, “the Group”, and “Bioceres Crop Solutions” will refer to Bioceres Crop Solutions Corp. and its subsidiaries.

ACCOUNTING STANDARDS AND BASIS

ACCOUNTING STANDARDS AND BASIS OF PREPARATION	6 Months Ended
	Dec. 31, 2021
ACCOUNTING STANDARDS AND BASIS OF PREPARATION
ACCOUNTING STANDARDS AND BASIS OF PREPARATION	2. ACCOUNTING STANDARDS AND BASIS OF PREPARATION Statement of compliance with IFRS as issued by IASB These unaudited interim condensed consolidated financial statements for the six-month period ended December 31, 2021, have been prepared in accordance with Accounting Standard IAS 34 Interim Financial Reporting. These unaudited interim condensed consolidated financial statements do not include all notes of the type normally included in an annual financial statement. Accordingly, these unaudited interim condensed consolidated financial statements are to be read in conjunction with the consolidated financial statements as of June 30, 2021. Authorization for the issue of the unaudited interim condensed consolidated financial statements These unaudited interim condensed consolidated financial statements of the Group as of December 31, 2021, June 30, 2021 and for the six-month periods ended December 31, 2021 and 2020 were authorized by the Board of Directors of Bioceres Crop Solutions Corp. on February 25, 2022. Basis of measurement The unaudited interim condensed consolidated financial statements of the Group have been prepared using: ● ● Functional currency and presentation currency a) Functional currency Items included in the financial statements of each of the Group’s entities are measured using the currency of the primary economic market in which the entity operates (i.e., “the functional currency”). IAS 29 “Financial reporting in hyperinflationary economies” requires that the financial statements of an entity whose functional currency is the currency of a hyperinflationary economy, whether these are based on the historical cost method or the current cost method, be stated in terms of the measuring unit current at the closing date of the reporting period. For such purpose, the inflation produced since the acquisition date or the revaluation date, as applicable, must be computed in non-monetary items. The standard details a series of factors to be considered for concluding whether an economy is hyperinflationary, including, but not limited to, a cumulative inflation rate over a three-year period that approaches or exceeds 100%. Inflation accumulated in three years, as of June 30, 2018, was over 100%. It was for this reason that, in accordance with IAS 29, the Argentine economy had to be considered as hyperinflationary since July 1, 2018. Consequently, the Group has applied IAS 29 to these financial statements. In an inflationary period, any entity that maintains an excess of monetary assets over monetary liabilities, will lose purchasing power, and any entity that maintains an excess of monetary liabilities over monetary assets, will gain purchasing power, provided that such items are not subject to an adjustment mechanism. Briefly, the restatement mechanism of IAS 29 establishes that monetary assets and liabilities will not be restated because they are already expressed in a current unit of measurement at the end of the reporting period. Assets and liabilities subject to adjustments based on specific agreements, will be adjusted according to those agreements. Non-monetary items measured at their current values at the end of the reporting period, such as the net realizable value or others, do not need to be restated. The remaining non-monetary assets and liabilities will be restated according to a general price index. The loss or gain for the net monetary position will be included in the net result of the reporting period, revealing this information in a separate line item. The inflation adjustment to the initial balances was calculated by means of a conversion factor derived from the Argentine price indexes published by the National Institute of Statistics. The index as of December 31, 2020 and June 30, 2020 was 385.8826 and 321.9738, respectively. The index as of December 31, 2021 and June 30, 2021 was 582.4575 and 483.6049, respectively. The comparative figures in these unaudited interim condensed consolidated financial statements presented in a stable currency are not adjusted for subsequent changes in the price levels or exchange rates. b) Presentation currency The unaudited interim condensed consolidated financial statements of the Group are presented in US Dollars, which is the presentation currency. c) Foreign currency Transactions entered into by Group entities in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchanges rates as of the final day of each reporting period. Exchange differences arising from the retranslation of unsettled monetary assets and liabilities are recognized immediately in profit or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation for which exchange differences are recognized in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences arising from the retranslation of the foreign operation. Upon the disposal of a foreign operation, the cumulative exchange differences recognized in the foreign exchange reserve relating to such operation up to the date of disposal are transferred to the consolidated statement of profit or loss and other comprehensive income as part of the gain or loss recognized upon such disposal. Changes in accounting policies The accounting policies adopted in the preparation of these unaudited interim condensed consolidated financial statements are consistent with those adopted for the preparation of the consolidated financial statements as of June 30, 2021. Revisions to previously issued unaudited interim condensed consolidated statements of cash flows The Group has revised the figures presented in our unaudited interim condensed consolidated statements of cash flows as of December 31, 2020. Based on their nature, we changed certain amounts previously shown as short-term investments to cash equivalents and the reporting of the purchases of own shares from investment activities to financing activities. The impact of these changes was considered non-material and is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, 2020 ​ Previously ​ ​ ​ ​ reported ​ Adjustments ​ As revised INVESTMENT ACTIVITIES Proceeds from sales of financial assets 12,732,709 (12,732,709) — Investment in financial assets — (2,630,731) (2,630,731) Purchase of own shares (1,608,560) 1,608,560 — Net cash flows generated (used in) by investing activities 11,124,149 (13,754,880) (2,630,731) ​ ​ ​ ​ ​ ​ ​ FINANCING ACTIVITIES Purchase of own shares — (1,608,560) (1,608,560) Net cash flows used in by financing activities — (1,608,560) (1,608,560) ​ ​ ​ ​ ​ ​ ​ Net increase (decrease) in cash and cash equivalents (8,303,787) (15,363,440) (23,667,227) ​ ​ ​ ​ ​ ​ ​ Inflation effects on cash and cash equivalents (403,950) (1,251,193) (1,655,143) ​ ​ ​ ​ ​ ​ ​ Cash and cash equivalents as of beginning of the period 27,159,421 15,363,440 42,522,861 Effect of exchange rate changes on cash and equivalents 678,522 1,251,193 1,929,715 Cash and cash equivalents as of the end of the period 19,130,206 — 19,130,206 ​

NEW STANDARDS, AMENDMENTS AND I

NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB	6 Months Ended
	Dec. 31, 2021
NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB
NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB	3. NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB a) Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 - Interest Rate Benchmark Reform (Phase 2) The Phase 2 amendments, Interest Rate Benchmark Reform—Phase 2, address issues that might affect financial reporting during the reform of an interest rate benchmark, including the effects of changes to contractual cash flows or hedging relationships arising from the replacement of an interest rate benchmark with an alternative benchmark rate (replacement issues). In 2019, the Board issued its initial amendments in Phase 1 of the project. The amendments are related to changes in the basis for determining contractual cash flows of financial assets, financial liabilities and lease liabilities; hedge accounting; and disclosures. They apply only to changes required by the interest rate benchmark reform to financial instruments and hedging relationships. The amendments are effective for financial years beginning on or after January 1, 2021. Earlier application is permitted. Covid-19-Related Rent Concessions beyond 30 June 2021 The International Accounting Standards Board extended by one year the application period of the practical expedient in IFRS 16 Leases to help lessees accounting for covid-19-related rent concessions. In response to calls from stakeholders and because the covid-19 pandemic is still at its height, the Board has extended the relief by one year to cover rent concessions that reduce only lease payments due on or before 30 June 2022. The original amendment permitted lessees, as a practical expedient, not to assess whether particular rent concessions occurring as a direct consequence of the covid-19 pandemic are lease modifications and, instead, to account for those rent concessions as if they were not lease modifications. The amendment is effective for annual reporting periods beginning on or after 1 April 2021. b) The following new standards are not yet adopted by the Group. Initial Application of IFRS 17 and IFRS 9 - Comparative Information The amendment is a transition option relating to comparative information about financial assets presented on initial application of IFRS 17. The amendment is aimed at helping entities to avoid temporary accounting mismatches between financial assets and insurance contract liabilities. IFRS 17 incorporating the amendment is effective for annual reporting periods beginning on or after 1 January 2023. It is not expected to have material impact on the Group.

IMPACT OF COVID-19

IMPACT OF COVID-19	6 Months Ended
	Dec. 31, 2021
IMPACT OF COVID-19
IMPACT OF COVID-19	4. IMPACT OF COVID-19 The Group's operations, which involve agricultural production and commercialization activities, have been mostly exempted from the disruptions caused by COVID-19. Consequently, our financial condition, liquidity position and results of operations have not been materially impacted as we have been allowed to continue with our operations. ​ The eventual scope of COVID-19 outbreak and its impact on the countries and global economy are unknown, with governments being able to implement stricter containment measures, which are not predictable in this instance. It cannot be reasonably quantified to what extent COVID-19 will affect the Group’s business and the results of its operations in the future if this situation is prolonged. The Board of Directors and senior management are closely monitoring the situation and taking all necessary measures at their disposal to protect human life and the Group's operations and financial condition.

SEASONALITY

SEASONALITY	6 Months Ended
	Dec. 31, 2021
SEASONALITY
SEASONALITY	5. SEASONALITY The Group revenues fluctuate depending on the timing of orders from our distributors and customers and on prevailing seed market prices, which influence the purchase decisions of growers, the end-users of seed and integrated products, crop protection products and crop nutrition products. Given the cyclicality of crop planting and harvesting and South America’s planting and growing seasons, which vary from year to year, our business is highly seasonal. This results in substantial fluctuations in quarterly sales and profitability. Generally, the Group sales are concentrated in the third and fourth quarters of each calendar year, when demand for seed and integrated products, crop protection products and crop nutrition products increases as South American growers begin planting their fields. Regarding the seed and integrated products business, the Group contracts with growers and seed suppliers based upon anticipated market demand that we forecast. Generally, in the seed and integrated products business we stock the seed during the harvest season and ship from inventory throughout the year, with the objective of selling most of the inventory from the current year’s harvest before the next year’s, with crop protection and crop nutrition business following a cycle similar to the seed cycle. The impact of seasonality and the resulting fluctuations in quarterly results may be lessened as we achieve our international expansion plans for the seed and integrated products business in geographies with complementary seasons and climates.

INFORMATION ABOUT COMPONENTS OF

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION	6 Months Ended
	Dec. 31, 2021
INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION	6. INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION 6.1. Cash and cash equivalents ​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Cash at bank and on hand ​ 35,966,810 ​ 28,327,569 Money market funds ​ 399,321 ​ 7,718,544 ​ 36,366,131 36,046,113 ​ 6.2. Other financial asset ​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Current Restricted short-term deposits 245,293 425,976 US Treasury bills ​ 1,885,553 ​ 7,885,937 Other investments 1,476,793 2,849,485 ​ 3,607,639 11,161,398 ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Non-current Shares of Bioceres S.A. 398,567 355,251 Other investments 470,465 742,211 ​ 869,032 1,097,462 ​ 6.3. Trade receivables ​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Current ​ ​ ​ ​ Trade debtors ​ 106,971,920 ​ 87,709,287 Allowance for impairment of trade debtors (6,405,009) (5,858,503) Shareholders and other related parties (Note 15) 444,095 — Allowance for credit notes to be issued (1,848,700) (2,987,398) Trade debtors - Joint ventures and associates (Note 15) 1,741,964 221,048 Deferred checks 18,380,786 9,699,738 ​ ​ 119,285,056 88,784,172 ​ ​ ​ ​ ​ Non-current ​ ​ ​ ​ Trade debtors ​ 121,234 ​ 135,739 ​ 121,234 ​ 135,739 ​ 6.4. Other receivables ​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Current Taxes 8,131,277 6,048,533 Other receivables - Other related parties (Note 15) 1,441 1,547 Other receivables - Parents companies and related parties to Parents (Note 15) — 770,549 Other receivables - Joint ventures and associates (Note 15) 2,679,918 2,219,863 Prepayments to suppliers 4,683,139 1,646,614 Prepayments to suppliers - Shareholders and other related parties (Note 15) 127,726 132,625 Reimbursements over exports 10,548 10,547 Prepaid expenses and other receivables 120,011 1,021 Loans receivables 230,000 230,000 Miscellaneous 271,690 92,406 ​ 16,255,750 11,153,705 ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Non-current ​ ​ Taxes 171,237 862,771 Reimbursements over exports 1,639,408 1,680,371 ​ 1,810,645 2,543,142 ​ 6.5. Inventories ​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Seeds 1,047,603 404,774 Resale products 31,157,840 21,368,521 Manufactured products 14,169,831 10,902,683 Goods in transit 1,287,904 1,169,303 Supplies 10,209,965 6,320,594 Agricultural products 31,031,179 21,984,626 Allowance for obsolescence (1,595,610) (1,112,950) ​ ​ 87,308,712 ​ 61,037,551 ​ ​ ​ ​ ​ Net of agricultural products 56,277,533 39,052,925 ​ 6.6. Biological assets ​ Changes in biological assets ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Soybean ​ Corn Wheat Barley HB4 Soy HB4 Wheat Total Beginning of the period ​ 54,162 ​ 27,646 ​ 22,311 ​ 3,071 ​ — ​ 2,208,648 ​ 2,315,838 Initial recognition and changes in the fair value of biological assets — — 292,692 141,899 — 1,708,237 2,142,828 Costs incurred during the period 378,530 649,680 172,957 81,661 1,099,241 33,153,682 35,535,751 Exchange differences 6,622 3,379 2,726 4,039 — 58,841 75,607 Decrease due to harvest — — (490,686) (230,670) — (31,205,748) (31,927,104) Period ended December 31, 2021 439,314 680,705 — — 1,099,241 5,923,660 8,142,920 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Soybean Corn Wheat Barley HB4 Soy HB4 Wheat Total Beginning of the period 105,101 271,754 45,639 34,050 ​ — 509,184 ​ 965,728 Initial recognition and changes in the fair value of biological assets 174,578 129,785 239,266 25,377 ​ (149,702) 564,889 ​ 984,193 Costs incurred during the period 259,760 442,922 254,909 45,490 ​ 10,371,418 4,667,032 ​ 16,041,531 Exchange differences (371,625) (80,335) (28,376) (9,251) ​ (844,644) (378,411) ​ (1,712,642) Decrease due to harvest / disposals (87,982) (110,192) (135,089) (28,504) ​ — (5,362,694) ​ (5,724,461) Period ended December 31, 2020 79,832 653,934 376,349 67,162 ​ 9,377,072 — ​ 10,554,349 ​ 6.7. Property, plant and equipment Property, plant and equipment as of December 31, 2021 and June 30, 2021 included the following: ​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Gross carrying amount 67,386,521 63,974,402 Accumulated depreciation (18,439,966) (16,019,806) Net carrying amount 48,946,555 47,954,596 ​ Net carrying amount for each class of assets is as follows: ​ ​ ​ ​ ​ ​ ​ ​ Net carrying ​ Net carrying ​ ​ amount ​ amount Class 12/31/2021 06/30/2021 Office equipment ​ 244,773 ​ 288,920 Vehicles ​ 2,387,064 ​ 1,835,634 Equipment and computer software 142,803 67,105 Fixtures and fittings 3,501,808 2,967,431 Machinery and equipment 5,493,935 5,125,728 Land and buildings 35,112,872 35,674,513 Buildings in progress 2,063,300 1,995,265 Total 48,946,555 47,954,596 ​ 1. Gross carrying amount as of December 31, 2021 is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross carrying amount ​ ​ As of the ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ beginning ​ ​ ​ ​ ​ ​ ​ Foreign ​ ​ ​ As of the ​ ​ of the ​ ​ ​ ​ ​ ​ ​ currency ​ ​ ​ end of the Class period Additions Transfers Disposals translation Revaluation period Office equipment ​ 762,825 ​ 17,009 ​ (55,698) ​ — ​ 69,188 ​ — ​ 793,324 Vehicles ​ 3,512,217 ​ 715,492 ​ 55,698 ​ (218,344) ​ 258,800 ​ — ​ 4,323,863 Equipment and computer software ​ 592,126 ​ 101,156 ​ — ​ (49,944) ​ 55,471 ​ — ​ 698,809 Fixtures and fittings ​ 5,637,943 ​ — ​ 356,109 ​ (15) ​ 821,362 ​ — ​ 6,815,399 Machinery and equipment 9,987,811 ​ 371,583 ​ 68,805 (41,468) 1,033,450 — 11,420,181 Land and buildings 41,486,215 ​ — ​ 168,569 — 4,099,357 (4,482,496) 41,271,645 Buildings in progress 1,995,265 ​ 551,106 ​ (593,483) (127,338) 237,750 — 2,063,300 Total 63,974,402 ​ 1,756,346 ​ — (437,109) 6,575,378 (4,482,496) 67,386,521 ​ 2. Accumulated depreciation as of December 31, 2021 is as follows ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Depreciation ​ ​ Accumulated ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ as of the ​ ​ ​ ​ ​ Foreign ​ ​ ​ Accumulated ​ ​ beginning of ​ ​ ​ Of the ​ currency ​ ​ ​ as of the end Class the period Disposals period translation Revaluation of period Office equipment ​ 473,905 ​ — ​ 23,583 ​ 51,063 ​ — ​ 548,551 Vehicles ​ 1,676,583 ​ (196,985) ​ 413,229 ​ 43,972 ​ — ​ 1,936,799 Equipment and computer software ​ 525,021 ​ (49,631) ​ 48,637 ​ 31,979 ​ — ​ 556,006 Fixtures and fittings ​ 2,670,512 ​ — ​ 327,792 ​ 315,287 ​ — ​ 3,313,591 Machinery and equipment 4,862,083 (4,492) 516,171 552,484 — 5,926,246 Land and buildings 5,811,702 — 339,376 700,325 (692,630) 6,158,773 Total 16,019,806 (251,108) 1,668,788 1,695,110 (692,630) 18,439,966 ​ 3. Gross carrying amount as of December 31, 2020, is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross carrying amount ​ ​ As of the ​ ​ ​ ​ ​ Foreign ​ ​ ​ As of the ​ ​ beginning ​ ​ ​ ​ ​ currency ​ ​ ​ end of Class of period Additions Disposals translation Revaluation period Office equipment ​ 579,882 ​ 42,546 ​ (5,103) ​ 1,474 ​ — ​ 618,799 Vehicles ​ 2,977,542 ​ 898,190 ​ (189,537) ​ 33,791 ​ — ​ 3,719,986 Equipment and computer software ​ 465,679 ​ 37,882 ​ — ​ 3,477 ​ — ​ 507,038 Fixtures and fittings ​ 5,480,431 ​ 1,506 ​ — ​ (32,276) ​ — ​ 5,449,661 Machinery and equipment 9,054,701 267,275 — (170,499) — 9,151,477 Land and buildings 34,698,618 57,252 — 118,430 (189,731) 34,684,569 Buildings in progress 1,270,539 451,324 — (4,188) — 1,717,675 Total 54,527,392 1,755,975 (194,640) (49,791) (189,731) 55,849,205 ​ 4. Accumulated depreciation as of December 31, 2020, is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Depreciation ​ ​ Accumulated ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ as of the ​ ​ ​ ​ ​ Foreign ​ ​ ​ Accumulated ​ ​ beginning of ​ ​ ​ Of the ​ currency ​ ​ ​ as of the end Class period Disposals period translation Revaluation of period Office equipment ​ 391,602 ​ (2,964) ​ 19,750 ​ 702 ​ — ​ 409,090 Vehicles ​ 1,828,087 ​ (117,085) ​ 289,400 ​ (2,031) ​ — ​ 1,998,371 Equipment and computer software ​ 433,231 ​ — ​ 20,737 ​ 1,315 ​ — ​ 455,283 Fixtures and fittings 1,801,356 ​ — 169,806 5,607 — 1,976,769 Machinery and equipment 3,605,468 ​ — 291,265 11,406 — 3,908,139 Land and buildings 4,952,542 ​ — 313,579 16,187 (48,917) 5,233,391 Total 13,012,286 ​ (120,049) 1,104,537 33,186 (48,917) 13,981,043 ​ The depreciation charge is included in Notes 7.3 and 7.4. Revaluation of property, plant and equipment At a minimum, the Group updates its assessment of the fair value of its land and buildings at the end of each reporting year (after the revaluation policy was adopted), considering the most recent independent valuations and market data. As of December 31, 2021, the Group reviewed these valuations in order to determine the variations between the fair values and their book value, taking into consideration the valuations made in June 2021. Management determined the property, plant and equipment’s value within a range of reasonable fair value estimates. All resulting fair value estimates for land and buildings are classified as Level 3 and are consistent with the methodology disclosed in the annual financial statements. 6.8. Intangible assets Intangible assets as of December 31, 2021 and June 30, 2021 included the following: ​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Gross carrying amount 85,908,018 78,019,203 Accumulated amortization (13,345,000) (10,676,841) Net carrying amount 72,563,018 67,342,362 ​ Net carrying amount of each class of intangible assets is as follows: ​ ​ ​ ​ ​ ​ ​ ​ Net carrying ​ Net carrying ​ ​ amount ​ amount Class 12/31/2021 06/30/2021 Seed and integrated products ​ ​ ​ HB4 soy and breeding program 29,451,462 27,611,142 Integrated seed products 2,848,985 2,558,220 Crop nutrition ​ ​ ​ Microbiological products 4,721,078 3,996,657 Other intangible assets ​ ​ ​ Trademarks and patents 7,330,948 6,923,256 Software 2,261,197 1,849,041 Customer loyalty 20,949,348 19,404,046 RG/RS/OX Wheat ​ 5,000,000 ​ 5,000,000 Total 72,563,018 67,342,362 ​ 1. Gross carrying amount as of December 31, 2021 is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross carrying amount ​ ​ As of the ​ ​ ​ Foreign ​ As of the ​ ​ beginning of ​ ​ ​ currency ​ end of the Class the period Additions translation period Seed and integrated products ​ ​ ​ ​ ​ ​ ​ ​ HB4 soy and breeding program ​ 27,611,142 ​ 1,840,320 ​ — ​ 29,451,462 Integrated seed products ​ 2,558,220 ​ — ​ 290,765 ​ 2,848,985 Crop nutrition ​ ​ ​ ​ ​ ​ ​ ​ Microbiological products 6,037,680 584,924 ​ 648,526 7,271,130 Other intangible assets ​ ​ ​ ​ ​ ​ ​ Trademarks and patents 9,824,171 — ​ 1,129,486 10,953,657 Software 3,784,593 346,268 ​ 508,279 4,639,140 Customer loyalty 23,203,397 — ​ 2,540,247 25,743,644 RG/RS/OX Wheat ​ 5,000,000 ​ — ​ — ​ 5,000,000 Total 78,019,203 2,771,512 ​ 5,117,303 85,908,018 ​ 2. Accumulated amortization as of December 31, 2021 is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amortization ​ ​ Accumulated ​ ​ ​ Foreign ​ Accumulated as ​ ​ as of beginning ​ ​ ​ currency ​ of the end of the Class of the period Of the period translation period Crop nutrition ​ ​ ​ ​ Microbiological products ​ 2,041,023 ​ 259,522 ​ 249,507 ​ 2,550,052 Other intangible assets ​ ​ ​ ​ ​ ​ ​ Trademarks and patents ​ 2,900,915 ​ 368,581 ​ 353,213 ​ 3,622,709 Software 1,935,552 212,148 ​ 230,243 2,377,943 Customer loyalty 3,799,351 535,747 ​ 459,198 4,794,296 Total 10,676,841 1,375,998 ​ 1,292,161 13,345,000 ​ 3. Gross carrying amount as of December 31, 2020 is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross ​ ​ As ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ beginning ​ ​ ​ ​ ​ Foreign currency ​ As of the end of Class of period Additions Transfers translation period Seed and integrated products ​ ​ ​ HB4 soy and breeding program 1 7,345,923 ​ 19,063,357 ​ (186,804) ​ 609 ​ 26,223,085 Integrated seed products ​ 2,296,955 ​ — ​ — ​ 7,537 ​ 2,304,492 Crop nutrition ​ ​ ​ ​ Microbiological products 3,867,593 922,937 ​ — 21,369 4,811,899 Other intangible assets ​ ​ ​ ​ ​ Trademarks and patents 8,432,746 — ​ — 27,672 8,460,418 Software 2,088,929 502,137 ​ 186,804 5,092 2,782,962 Customer loyalty 18,800,691 — ​ — 61,693 18,862,384 GLA/ARA safflower ​ — ​ 2,931,699 ​ — ​ — ​ 2,931,699 Total 42,832,837 23,420,130 ​ — 123,972 66,376,939 ​ (1) ​ 4. Accumulated amortization as of December 31, 2020 is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amortization ​ ​ Accumulated as ​ ​ Foreign ​ Accumulated ​ ​ of beginning of ​ ​ ​ currency ​ as of the end Class period Of the period translation of period Crop nutrition ​ Microbiological products 1,363,962 229,417 5,407 1,598,786 Other intangible assets ​ ​ ​ Trademarks and patents 2,057,964 279,016 6,754 2,343,734 Software 1,401,964 200,277 3,695 1,605,936 Customer loyalty 2,675,483 362,738 8,779 3,047,000 Total 7,499,373 1,071,448 24,635 8,595,456 ​ The amortization charge is included in Notes 7.3 and 7.4. 6.9. Goodwill The variations in goodwill that occurred during the period correspond to the result of inflation adjustment and conversion to presentation currency. There were no indicators of goodwill impairment. Carrying amount of goodwill as of December 31, 2021 and June 30, 2021 is as follows: ​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Rizobacter Argentina S.A. 25,080,278 22,277,336 Bioceres Crops S.A. ​ 6,737,752 ​ 6,003,780 Insumos Agroquímicos S.A. ​ 470,090 ​ 470,090 ​ 32,288,120 28,751,206 ​ 6.10. Trade and other payables ​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Current ​ ​ ​ ​ Trade creditors 82,253,229 51,389,515 Shareholders and other related parties (Note 15) 53,661 52,864 Trade creditors - Parent company (Note 15) 182,812 193,718 Trade creditors - Joint ventures and associates (Note 15) 21,113,841 17,669,027 Taxes 2,138,995 2,556,945 Miscellaneous 273,704 229,339 ​ 106,016,242 72,091,408 ​ 6.11. Borrowings ​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Current ​ ​ ​ ​ Bank overdrafts — 32,838 Bank borrowings 36,004,973 33,684,287 Corporate bonds 5,358,525 24,742,752 Trust debt securities ​ 3,080,286 ​ 3,470,448 Net loans payables- Parents companies and related parties to Parents (Note 15) 3,697,715 3,578,921 Other finance debt ​ 89,164 ​ — Subordinated loan ​ — ​ 11,276,611 ​ 48,230,663 76,785,857 Non-current ​ ​ Bank borrowings 8,656,385 4,161,827 Corporate bonds 74,004,867 37,826,641 Net loans payables- Parents companies and related parties to Parents (Note 15) 6,000,000 6,000,000 Trust debt securities 2,076,976 — ​ ​ 90,738,228 ​ 47,988,468 ​ On December 23, 2021,we completed a $20 million public offering of Series VII corporate bonds in the Argentine market. The bonds mature in December 2024 and pay an annual nominal interest rate of 1.49%. The carrying value of some borrowings as of December 31, 2021 measured at amortized cost differs from the fair value of these borrowings. The following measures of fair values are based on discounted cash flows (Level 3), due to the use of unobservable inputs, including own credit risk. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 12/31/2021 ​ 06/30/2021 ​ ​ Amortized cost ​ Fair value ​ Amortized cost ​ Fair value Current ​ ​ ​ ​ ​ ​ ​ ​ Bank borrowings 36,004,973 34,440,750 33,684,287 32,770,615 Corporate Bonds 5,358,525 5,322,676 24,742,752 24,085,087 ​ ​ ​ ​ ​ ​ ​ ​ ​ Non-current ​ ​ Bank borrowings 8,656,385 7,985,438 4,161,827 3,864,666 Corporate Bonds 74,004,867 68,109,433 37,826,641 32,656,097 ​ The Group has met the capital and interest installments whose maturity were effective in the six-month period ended December 31, 2021. 6.12. Employee benefits and social security ​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Current ​ ​ ​ ​ Salaries, accrued incentives, vacations and social security 6,201,169 4,243,585 Key management personnel (Note 15) ​ 270,909 ​ 436,493 ​ ​ 6,472,078 ​ 4,680,078 ​

INFORMATION ABOUT COMPONENTS _2

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME	6 Months Ended
	Dec. 31, 2021
INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME	7. INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME 7.1. Revenues from contracts with customers ​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 Sale of goods and services 157,538,626 88,616,572 Royalties 1,129,024 1,492,026 ​ 158,667,650 90,108,598 ​ Transactions of sales of goods and services with joint ventures, shareholders and other related parties are reported in Note 15. 7.2. Cost of sales ​ ​ ​ ​ ​ ​ Item 12/31/2021 12/31/2020 Inventories as of the beginning of the period 39,052,925 29,338,548 Purchases of the period 102,342,174 56,271,944 Production costs 7,581,570 5,514,975 Foreign currency translation 516,306 (1,283,574) Subtotal 149,492,975 89,841,893 Inventories as of the end of the period 1 (56,277,533) (41,655,409) Cost of sales 93,215,442 48,186,484 ​ (1) Net of agricultural products. ​ 7.3. R&D classified by nature ​ ​ ​ ​ ​ ​ ​ Research and Research and ​ ​ development ​ development ​ expenses expenses Item 12/31/2021 12/31/2020 Amortization of intangible assets 604,462 508,433 Import and export expenses 1,685 9,322 Depreciation of property, plant and equipment 213,837 69,860 Employee benefits and social securities 685,412 496,967 Maintenance 25,702 14,045 Energy and fuel 24,659 17,564 Supplies and materials 726,899 460,272 Mobility and travel 38,564 4,668 Share-based incentives 30,099 — Professional fees and outsourced services 137,674 67,550 Professional fees related parties ​ 296,967 ​ 466,144 Office supplies 2,842 2,467 Information technology expenses ​ 6,039 ​ 9,992 Insurance 12,598 8,326 Depreciation of leased assets ​ 2,523 ​ 1,279 Miscellaneous 5,612 2,143 Total 2,815,574 2,139,032 ​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 R&D capitalized (Note 6.8) 2,425,244 1,556,367 R&D profit and loss 2,815,574 2,139,032 Total 5,240,818 3,695,399 ​ 7.4. Expenses classified by nature and function ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Selling, ​ ​ ​ ​ general and ​ ​ ​ ​ Production ​ administrative ​ Total Item ​ costs ​ expenses ​ 12/31/2021 Amortization of intangible assets — ​ 771,536 ​ 771,536 Analysis and storage 26,537 ​ 69,502 ​ 96,039 Commissions and royalties 547,364 ​ 1,181,465 ​ 1,728,829 Import and export expenses 61,209 ​ 560,934 ​ 622,143 Depreciation of property, plant and equipment 655,067 ​ 799,884 ​ 1,454,951 Depreciation of leased assets ​ 246,942 ​ 251,767 ​ 498,709 Impairment of receivables — ​ 815,929 ​ 815,929 Freight and haulage 311,416 ​ 4,457,096 ​ 4,768,512 Employee benefits and social securities 3,265,750 ​ 11,033,554 ​ 14,299,304 Maintenance 400,778 ​ 570,294 ​ 971,072 Energy and fuel 233,958 ​ 24,908 ​ 258,866 Supplies and materials 351,410 ​ 570,762 ​ 922,172 Mobility and travel 7,361 ​ 696,370 ​ 703,731 Publicity and advertising — ​ 2,247,729 ​ 2,247,729 Contingencies — ​ 65,598 ​ 65,598 Share-based incentives ​ — ​ 843,308 ​ 843,308 Professional fees and outsourced services 587,370 ​ 3,075,667 ​ 3,663,037 Professional fees related parties — ​ 48,934 ​ 48,934 Office supplies 89,670 ​ 198,228 ​ 287,898 Insurance 36,328 ​ 556,441 ​ 592,769 Information technology expenses — ​ 817,032 ​ 817,032 Obsolescence 740,264 ​ — ​ 740,264 Taxes 19,398 ​ 5,230,416 ​ 5,249,814 Miscellaneous 748 ​ 110,407 ​ 111,155 Total 7,581,570 ​ 34,997,761 ​ 42,579,331 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Selling, ​ ​ ​ ​ ​ general and ​ ​ ​ ​ Production ​ administrative ​ Total Item ​ costs ​ expenses ​ 12/31/2020 Amortization of intangible assets — 563,015 563,015 Analysis and storage 18,651 46,251 64,902 Commissions and royalties 767,326 287,445 1,054,771 Import and export expenses 29,128 434,113 463,241 Depreciation of property, plant and equipment 560,806 473,871 1,034,677 Depreciation of leased assets ​ 125,226 ​ 160,979 ​ 286,205 Impairment of receivables — 126,593 126,593 Freight and haulage 248,785 2,023,017 2,271,802 Employee benefits and social securities 2,260,596 7,010,150 9,270,746 Maintenance 282,937 259,182 542,119 Energy and fuel 156,666 23,848 180,514 Supplies and materials 187,315 58,212 245,527 Mobility and travel 1,593 369,382 370,975 Publicity and advertising — 1,062,884 1,062,884 Contingencies — 52,441 ​ 52,441 Share-based incentives ​ — ​ 636,519 ​ 636,519 Professional fees and outsourced services 335,681 4,040,404 4,376,085 Professional fees related parties — 113,888 113,888 Office supplies 89,049 150,121 239,170 Insurance 68,033 392,752 460,785 Information technology expenses 849 530,970 531,819 Obsolescence 365,458 — 365,458 Taxes 16,609 2,431,415 2,448,024 Miscellaneous 267 64,507 64,774 Total 5,514,975 21,311,959 26,826,934 ​ 7.5. Finance results ​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 Financial costs ​ ​ ​ ​ Interest expenses with the Parents (Note 15) (415,812) (634,128) Interest expenses (5,439,593) (9,043,815) Financial commissions (907,660) (964,237) ​ (6,763,065) (10,642,180) ​ ​ ​ ​ ​ Other financial results ​ ​ ​ Exchange differences generated by assets 6,355,520 10,714,855 Exchange differences generated by liabilities ​ (11,682,895) ​ (16,991,043) Changes in fair value of financial assets or liabilities and other financial results ​ (1,652,984) ​ (5,466,867) Net gain of inflation effect on monetary items ​ 342,135 ​ 3,752,899 ​ ​ (6,638,224) ​ (7,990,156) ​ ​ ​ ​ ​ Total net financial results (13,401,289) (18,632,336) ​

TAXATION

TAXATION	6 Months Ended
	Dec. 31, 2021
TAXATION
TAXATION	8. TAXATION Taxes on income in the interim periods are accrued using the tax rate that would be applicable to expected total annual earnings. ​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 Current tax expense (11,916,178) (6,716,736) Deferred tax 5,179,763 875,283 Total ​ (6,736,415) ​ (5,841,453) ​ The gross movement on the deferred income tax account is as follows: ​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 Beginning of the period deferred tax (22,421,125) (14,164,930) Charge of the period 5,179,763 875,283 Charge to OCI ​ 1,326,453 ​ 35,204 Conversion difference ​ (2,993,421) ​ (145,175) Total net deferred tax (18,908,330) (13,399,618) ​ The tax on the Group’s profit before tax differs from the theoretical amount that would arise using the weighted average tax rate applicable to profits of the consolidated entities as follows: ​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 Earning before income tax-rate 14,340,137 1,270,149 Income tax expense by applying tax rate in force in the respective countries (7,314,555) (4,007,409) Share of profit or loss of subsidiaries, joint ventures and associates 269,138 100,552 Stock options charge (180,523) (29,199) Rate change adjustment — (163,269) Non-deductible expenses (315,241) (295,416) Representation expenses (3,039) (10,972) Foreign investment coverage 140,720 248,743 Tax inflation adjustment ​ 1,097,315 ​ (1,197,624) Result of inflation effect on monetary items and other finance results ​ (479,093) ​ (457,537) Others 48,863 (29,322) Income tax expenses (6,736,415) (5,841,453) ​

EARNINGS PER SHARE (EPS)

EARNINGS PER SHARE (EPS)	6 Months Ended
	Dec. 31, 2021
EARNINGS PER SHARE (EPS)
EARNINGS PER SHARE (EPS)	9. EARNINGS PER SHARE (EPS) The numerators and denominators used in the calculation of basic EPS and diluted EPS are presented below: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three -month period ended ​ Six -month period ended ​ 12/31/2021 12/31/2020 12/31/2021 12/31/2020 Numerator ​ ​ ​ ​ ​ Profit (loss) for the period (basic EPS) 3,427,093 ​ 648,193 ​ 4,301,230 (6,323,365) Profit (loss) for the period (diluted EPS) 3,427,093 ​ 648,193 ​ 4,301,230 (6,323,365) Denominator ​ ​ ​ ​ ​ ​ Weighted average number of shares (basic EPS) 41,104,331 ​ 38,016,601 ​ 41,104,331 38,016,601 Weighted average number of shares (diluted EPS) 42,403,196 ​ 39,038,280 ​ 42,403,196 38,016,601 ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic profit (loss) attributable to ordinary equity holders of the parent ​ 0.0834 ​ 0.0171 ​ 0.1046 ​ (0.1663) Diluted profit (loss) attributable to ordinary equity holders of the parent 0.0808 ​ 0.0166 ​ 0.1014 (0.1663) ​ For the six-month period ended December 31, 2020 diluted EPS was the same as basic EPS as the effect of potential ordinary shares would be antidilutive. Diluted earnings per share is calculated by adjusting the weighted average number of shares outstanding to assume conversion of all dilutive potential shares. The Group has two categories of dilutive potential shares, share-based incentives, and Convertible notes. The stock options were included in the diluted EPS calculation for the year ended December 31, 2021 only for the tranches in which the average market price of ordinary shares during the periods was higher than the assumed proceeds per option. See note 17. Convertible notes outstanding were not included in the diluted EPS calculations for the three-and-six month periods ended December 31, 2021 because its interest (net of tax and other changes in income or expense) per ordinary share obtainable on conversion exceeds basic earnings per share.

INFORMATION ABOUT UNAUDITED INT

INFORMATION ABOUT UNAUDITED INTERIM CONDENSED CONSOLIDATED COMPONENTS OF EQUITY	6 Months Ended
	Dec. 31, 2021
INFORMATION ABOUT UNAUDITED INTERIM CONDENSED CONSOLIDATED COMPONENTS OF EQUITY
INFORMATION ABOUT UNAUDITED INTERIM CONDENSED CONSOLIDATED COMPONENTS OF EQUITY	10. INFORMATION ABOUT UNAUDITED INTERIM CONDENSED CONSOLIDATED COMPONENTS OF EQUITY Share capital As of December 31, 2021, we had (i) 100,000,000 ordinary shares ($0.0001 par value) authorized, (ii) 41,105,321 ordinary shares issued and outstanding outstanding Holders of the ordinary shares are entitled to one vote for each ordinary share. Non-controlling interests On August 2, 2021, we acquired an incremental ownership of Insumos Agróquimicos S.A. (“Insuagro”). Consideration of payment of the 2,467,990 shares acquired was $0.7 million in cash as a Fixed Price. Furthermore, the Fixed Price may be increased up to 3.5x Adjusted EBITDA per share to be measured in each annual reporting period. The Group has recognized in equity the difference between the amount by which the non-controlling interests were incorporated and the fair value of the consideration paid. As of today, we own 13,489,990 shares of Insuagro, which represent 61.32% of the share capital and 61.22% of the votes.

CASH FLOW INFORMATION

CASH FLOW INFORMATION	6 Months Ended
	Dec. 31, 2021
CASH FLOW INFORMATION
CASH FLOW INFORMATION	11. CASH FLOW INFORMATION Significant non-cash transactions related to investment and financing activities are as follows: ​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 Investment activities ​ ​ ​ ​ Settlement of receivables through PPE contribution ​ — ​ 1,547,543 Investment in-kind in other related parties (Note 15) ​ 437,780 ​ 921,390 Acquisition of assets financed by debt — 7,637,972 Acquisition of assets through issuance of capital ​ — ​ 15,000,000 ​ ​ 437,780 ​ 25,106,905 ​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 Financing activities Acquisition of non-controlling interest in subsidiaries 255,893 — ​ 255,893 — ​

JOINT VENTURES AND ASSOCIATES

JOINT VENTURES AND ASSOCIATES	6 Months Ended
	Dec. 31, 2021
JOINT VENTURES AND ASSOCIATES
JOINT VENTURES AND ASSOCIATES	12. JOINT VENTURES AND ASSOCIATES ​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Assets Synertech Industrias S.A. 30,867,914 27,572,597 Indrasa Biotecnología S.A. 113,821 54,957 Alfalfa Technologies S.R.L. 91,240 97,920 Moolec Science Limited 2,981,982 2,931,699 ​ 34,054,957 30,657,173 ​ ​ ​ ​ ​ ​ Liabilities Trigall Genetics S.A. 616,173 1,278,250 ​ 616,173 1,278,250 ​ Share of profit or loss of joint ventures and associates: ​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 Trigall Genetics S.A. 662,077 (98,280) Synertech Industrias S.A. 319,356 376,635 Moolec Science Limited ​ (114,709) ​ — Indrasa Biotecnología S.A. 52,363 27,332 ​ 919,087 305,687 ​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 As of the beginning of the period 29,378,923 23,103,963 Revaluation of property, plant and equipment (363,848) (11,495) Foreign currency translation 3,504,622 49,996 Share of profit or loss 919,087 305,687 As of the end of the period 33,438,784 23,448,151 ​

SEGMENT INFORMATION

SEGMENT INFORMATION	6 Months Ended
	Dec. 31, 2021
SEGMENT INFORMATION
SEGMENT INFORMATION	13. SEGMENT INFORMATION The following tables present information with respect to the Group´s reporting segments: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Seed and ​ ​ ​ ​ integrated Crop Crop ​ ​ ​ Period ended December 31, 2021 products ​ protection ​ nutrition ​ Consolidated ​ Revenues from contracts with customers ​ ​ ​ ​ ​ ​ ​ ​ ​ Sale of goods and services 23,767,633 82,062,604 51,708,389 157,538,626 ​ Royalties 1,129,024 ​ ​ 1,129,024 ​ Others ​ ​ ​ ​ ​ ​ ​ ​ ​ Government grants ​ 805 ​ — ​ — ​ 805 ​ Initial recognition and changes in the fair value of biological assets 1,033,753 845,387 263,688 2,142,828 ​ Changes in the net realizable value of agricultural products after harvest ​ (821,078) ​ (304,522) ​ (116,585) ​ (1,242,185) ​ Total 25,110,137 82,603,469 51,855,492 159,569,098 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Cost of sales (8,988,420) (57,480,257) (26,746,765) (93,215,442) ​ Gross profit per segment 16,121,717 25,123,212 25,108,727 66,353,656 ​ % Gross margin ​ 64 % 30 % 48 % 42 % ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Seed and ​ ​ ​ ​ integrated Crop Crop ​ ​ ​ Period ended December 31, 2020 products ​ protection ​ nutrition ​ Consolidated ​ Revenues from contracts with customers ​ ​ ​ ​ ​ ​ ​ ​ ​ Sale of goods and services 19,191,676 48,577,062 20,847,834 88,616,572 ​ Royalties 1,492,026 ​ ​ 1,492,026 ​ Others ​ ​ ​ ​ ​ Government grants 1,160 — — 1,160 ​ Initial recognition and changes in the fair value of biological assets ​ 470,789 ​ 119,039 ​ 394,365 ​ 984,193 ​ Total 21,155,651 48,696,101 21,242,199 91,093,951 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Cost of sales (8,705,712) ​ (28,703,147) ​ (10,777,625) ​ (48,186,484) ​ Gross profit per segment 12,449,939 19,992,954 10,464,574 42,907,467 ​ % Gross margin ​ 59 % 41 % 49 % 47 % ​

FINANCIAL INSTRUMENTS - RISK MA

FINANCIAL INSTRUMENTS - RISK MANAGEMENT	6 Months Ended
	Dec. 31, 2021
FINANCIAL INSTRUMENTS - RISK MANAGEMENT
FINANCIAL INSTRUMENTS - RISK MANAGEMENT	14. FINANCIAL INSTRUMENTS – RISK MANAGEMENT The following tables show additional information required under IFRS 7 for financial assets and liabilities recorded as of December 31, 2021 and June 30, 2021. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Mandatorily measured at fair ​ ​ Amortized cost ​ value through profit or loss Financial asset 12/31/2021 06/30/2021 12/31/2021 06/30/2021 Cash and cash equivalents 35,966,810 28,327,569 399,321 7,718,544 Other financial assets 1,114,325 1,523,438 3,362,346 10,735,422 Trade receivables 119,406,290 88,919,911 — — Other receivables (*) 4,833,005 5,005,283 — — Total 161,320,430 123,776,201 3,761,667 18,453,966 ​ (*) Advances expenses and tax balances are not included. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Mandatorily measured at fair ​ ​ Amortized cost ​ value through profit or loss Financial liability 12/31/2021 06/30/2021 12/31/2021 06/30/2021 Trade and other payables 106,016,242 72,091,408 — — Borrowings 138,879,727 ​ 124,774,325 89,164 — Convertible notes ​ 48,890,332 ​ 48,664,012 ​ — ​ — Lease liability ​ 1,205,745 ​ 1,140,717 ​ — ​ — Employee benefits and social security 6,472,078 4,680,078 — — Consideration for acquisition of assets 12,443,071 11,790,533 — — Total 313,907,195 263,141,073 89,164 — ​ Financial instruments measured at fair value ​ ​ ​ ​ ​ ​ ​ ​ Measurement at fair value at 12/31/2021 Level 1 Level 2 Level 3 Financial assets at fair value ​ ​ ​ ​ ​ ​ Mutual funds ​ 399,321 ​ — ​ — US Treasury bills ​ 1,885,553 ​ — ​ — Other investments 1,476,793 — — ​ ​ ​ ​ ​ ​ ​ Financial liabilities at fair value ​ ​ ​ Other finance debt ​ — ​ 89,164 ​ — ​ ​ ​ ​ ​ ​ ​ Measurement at fair value at 06/30/2021 Level 1 Level 2 Level 3 Financial assets at fair value ​ ​ ​ ​ ​ ​ Mutual funds ​ 7,718,544 ​ — ​ — US Treasury bills 7,885,937 — — Other investments ​ 2,110,414 ​ 739,071 ​ — ​ Estimation of fair value The fair value of marketable securities, mutual funds and US Treasury Bills is calculated using the market approach, which use quoted prices in active markets for identical assets. The quoted marked price used for financial assets held by the Group is the current bid price. These instruments are included in level 1. The Group’s financial liabilities, which were not traded in an active market, were determined using valuation techniques that maximize the use of available market information, and thus rely as little as possible on specific estimates. If all significant inputs required to fair value an instrument are observable, the instruments are included in level 2. If one or more of the significant inputs is not based on observable market data, the instruments are included in Level 3. The Group’s policy is to recognize transfers between different categories of the fair value hierarchy at the time they occur or when there are changes in the circumstances that cause the transfer. There were no transfers between levels of the fair value hierarchy. There were no changes in economic or business circumstances affecting fair value. Financial instruments not measured at fair value The financial instruments not measured at fair value include cash and cash equivalents, trade accounts receivable, other accounts receivable, trade payables and other debts, borrowings, financed payments and convertible notes. The carrying value of financial instruments not measured at fair value does not differ significantly from their fair value, except for borrowings (Note 6.11). Management estimates that the carrying value of the financial instruments measured at amortized cost approximates their fair value.

SHAREHOLDERS AND OTHER RELATED

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS	6 Months Ended
	Dec. 31, 2021
SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS
SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS	15. SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS During the periods ended December 31, 2021 and 2020, the transactions between the Group and related parties, and the related balances owed by and to them, are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amount of transactions for the period ended Party Transaction type 12/31/2021 12/31/2020 Joint ventures and associates Sales and services 10,839,406 2,920,262 Joint ventures and associates Purchases of goods and services (29,026,646) (9,763,160) Joint ventures and associates Net loans granted — 18,409 Key management personnel Salaries, social security benefits and other benefits (1,677,312) (1,716,413) Key management personnel Net loans cancelled — (603,093) Key management personnel Interest gain — (8,879) Shareholders and other related parties Sales of goods and services 313,432 161,792 Shareholders and other related parties Purchases of goods and services (2,441,710) (399,888) Shareholders and other related parties In-kind contributions 437,780 921,390 Parent company and related parties to Parent (Note 7.5) Interest expenses (415,812) (634,128) Total (21,970,862) (9,103,708) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amounts receivable from related parties Party Transaction type 12/31/2021 06/30/2021 Parent company and related parties to Parent Other receivables — 770,549 Shareholders and other related parties Trade debtors 444,095 — Other receivables - Other related parties Other receivables 129,167 134,172 Joint ventures and associates Trade debtors 1,741,964 221,048 Joint ventures and associates Other receivables 2,679,918 2,219,863 Total ​ ​ 4,995,144 3,345,632 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amounts payable to related parties Party Transaction type 12/31/2021 06/30/2021 Parent company and related parties to Parent ​ Trade creditors ​ (182,812) ​ (193,718) Parent company and related parties to Parent ​ Net loans payables ​ (9,697,715) ​ (9,578,921) Key management personnel Salaries, social security benefits and other benefits (270,909) (436,493) Shareholders and other related parties Trade and other payables (53,661) (52,864) Joint ventures and associates Trade creditors (21,113,841) (17,669,027) Total ​ ​ (31,318,938) (27,931,023) ​

KEY MANAGEMENT PERSONNEL COMPEN

KEY MANAGEMENT PERSONNEL COMPENSATION	6 Months Ended
	Dec. 31, 2021
KEY MANAGEMENT PERSONNEL COMPENSATION
KEY MANAGEMENT PERSONNEL COMPENSATION	16. KEY MANAGEMENT PERSONNEL COMPENSATION The compensation of directors and other members of key management, including social security contributions and other benefits, was as follows for the period ended December 31, 2021 and 2020. ​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 ​ ​ ​ ​ ​ Salaries, social security and other benefits 803,905 1,079,894 Share-based incentives ​ 873,407 ​ 636,519 Total 1,677,312 1,716,413 ​

SHARE-BASED PAYMENTS

SHARE-BASED PAYMENTS	6 Months Ended
	Dec. 31, 2021
SHARE-BASED PAYMENTS
SHARE-BASED PAYMENTS	17. SHARE-BASED PAYMENTS a) Incentive payments based on options ● ● Options can be exercised on a cashless basis at their volume weighted average price (“VWAP”) of the ordinary shares during a twenty-day period to the date of exercise. The fair value of the stock options at the grant date was estimated using the “Black-Scholes” model, considering the terms and conditions under which the options on shares were granted and adjusted to consider the possible dilutive effect of the future exercise of options. ​ ​ ​ ​ ​ ​ ​ Directors and Junior Factor ​ Sr. Management ​ Management Weighted average fair value of shares $5.42 $13.98 Exercise price $4.55 $5.55 Weighted average expected volatility (*) 29.69% 42.18% Dividend rate 0% 0% Weighted average risk-free interest rate 1.66% 1.17% Weighted average expected life 9.89 years 9.22 years Weighted average fair value of stock options at measurement date $2.47 $10.1 ​ There are no market-related performance conditions or non-vesting conditions that should be considered for determining the fair value of options. ​ The Group estimates that 100% of the stock options will be exercised, taking into account historical patterns of executives maintaining their jobs and the probability of exercising the options. This estimate is reviewed at the end of each annual or interim period. ​ The following table shows the weighted average amount and exercise price and the movements of the stock options of executives and directors of the Group during the six-month periods ended December 31, 2021 and 2020. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 12/31/2021 ​ 12/30/2020 ​ ​ Number of ​ Exercise ​ Number of ​ Exercise ​ options price options price At the beginning 1,166,667 $ 4.55 1,200,000 $ 4.55 Granted during the period 93,600 $ 5.55 — ​ — Annulled during the period — ​ — — ​ — Exercised during the period (2,000) $ 5.55 — ​ — Expired during the period — ​ — — ​ — Effective at period(*) 1,258,267 $ 4.62 1,200,000 $ 4.55 ​ (*) The charge of the plans based on options recognized during the period was $0.6 million. b) Annual compensation - Bonus Bonus in Cash Bonus in Kind. The number of shares that can be awarded under each bonus will be determined by using a 20-day volume weighted average price (“VWAP”) of the Company’s ordinary shares, starting with the day on which the relevant financial and operational objectives are met by the Company and the bonus is granted. 50% of bonus vests immediately if the financial and operational objectives are achieved as of such date, and the remaining 50% vests in the subsequent 12-months, upon meeting of the financial and operational objectives.

LEASE

LEASE	6 Months Ended
	Dec. 31, 2021
LEASE
LEASE	18. LEASE ​ ​ ​ ​ ​ ​ Right-of-use leased asset 12/31/2021 06/30/2021 Book value at the beginning of the period 3,688,150 2,369,326 Additions of the period 612,579 913,321 Exchange differences ​ (156,673) ​ 405,503 Book value at the end of the year 4,144,056 3,688,150 ​ ​ ​ ​ ​ Depreciation 12/31/2021 06/30/2021 Book value at the beginning of the period ​ 2,360,490 ​ 1,254,729 Exchange differences (206,274) 278,441 Depreciation of the period 501,232 827,320 Accumulated depreciation at the end of the period 2,655,448 2,360,490 Total 1,488,608 1,327,660 ​ ​ ​ ​ ​ ​ Lease liability 12/31/2021 06/30/2021 Book value at the beginning of the period 1,140,717 1,109,812 Additions of the year 396,205 259,427 Interest expenses, exchange differences and inflation effects 162,276 500,442 Payments of the period (493,453) (728,964) Total 1,205,745 1,140,717 ​ ​ ​ ​ ​ ​ Lease Liabilities 12/31/2021 06/30/2021 Non-current 570,505 390,409 Current 635,240 750,308 Total 1,205,745 1,140,717 ​ The recognized right-of-use assets relate to the following types of assets: ​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Machinery and equipment 742,417 661,544 Vehicles 1,007,824 1,061,184 Equipment and computer software 668,160 582,101 Land and buildings 1,725,655 1,383,321 ​ 4,144,056 3,688,150 ​ The incremental borrowing rate used was 3.52%.

CONTINGENCIES, COMMITMENTS AND

CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS	6 Months Ended
	Dec. 31, 2021
CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS
CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS	19. CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS There were no significant changes to the contingencies, commitments and restrictions on the distribution of profits from the disclosure made in the Consolidated financial statement as of June 30, 2021.

EVENTS OCCURRING AFTER THE REPO

EVENTS OCCURRING AFTER THE REPORTING PERIOD	6 Months Ended
	Dec. 31, 2021
EVENTS OCCURRING AFTER THE REPORTING PERIOD
EVENTS OCCURRING AFTER THE REPORTING PERIOD	20. EVENTS OCCURRING AFTER THE REPORTING PERIOD Subsequent to December 31, 2021, there have been no situations or circumstances that may require significant adjustments or further disclosure in these unaudited interim condensed consolidated financial statements that were not mentioned above. ​

ACCOUNTING STANDARDS AND BASI_2

ACCOUNTING STANDARDS AND BASIS OF PRESENTATION (Policies)	6 Months Ended
	Dec. 31, 2021
ACCOUNTING STANDARDS AND BASIS OF PREPARATION
Basis of measurement	Basis of measurement The unaudited interim condensed consolidated financial statements of the Group have been prepared using: ● ●
Functional currency	a) Functional currency Items included in the financial statements of each of the Group’s entities are measured using the currency of the primary economic market in which the entity operates (i.e., “the functional currency”). IAS 29 “Financial reporting in hyperinflationary economies” requires that the financial statements of an entity whose functional currency is the currency of a hyperinflationary economy, whether these are based on the historical cost method or the current cost method, be stated in terms of the measuring unit current at the closing date of the reporting period. For such purpose, the inflation produced since the acquisition date or the revaluation date, as applicable, must be computed in non-monetary items. The standard details a series of factors to be considered for concluding whether an economy is hyperinflationary, including, but not limited to, a cumulative inflation rate over a three-year period that approaches or exceeds 100%. Inflation accumulated in three years, as of June 30, 2018, was over 100%. It was for this reason that, in accordance with IAS 29, the Argentine economy had to be considered as hyperinflationary since July 1, 2018. Consequently, the Group has applied IAS 29 to these financial statements. In an inflationary period, any entity that maintains an excess of monetary assets over monetary liabilities, will lose purchasing power, and any entity that maintains an excess of monetary liabilities over monetary assets, will gain purchasing power, provided that such items are not subject to an adjustment mechanism. Briefly, the restatement mechanism of IAS 29 establishes that monetary assets and liabilities will not be restated because they are already expressed in a current unit of measurement at the end of the reporting period. Assets and liabilities subject to adjustments based on specific agreements, will be adjusted according to those agreements. Non-monetary items measured at their current values at the end of the reporting period, such as the net realizable value or others, do not need to be restated. The remaining non-monetary assets and liabilities will be restated according to a general price index. The loss or gain for the net monetary position will be included in the net result of the reporting period, revealing this information in a separate line item. The inflation adjustment to the initial balances was calculated by means of a conversion factor derived from the Argentine price indexes published by the National Institute of Statistics. The index as of December 31, 2020 and June 30, 2020 was 385.8826 and 321.9738, respectively. The index as of December 31, 2021 and June 30, 2021 was 582.4575 and 483.6049, respectively. The comparative figures in these unaudited interim condensed consolidated financial statements presented in a stable currency are not adjusted for subsequent changes in the price levels or exchange rates.
Presentation currency	b) Presentation currency The unaudited interim condensed consolidated financial statements of the Group are presented in US Dollars, which is the presentation currency.
Foreign currency	c) Foreign currency Transactions entered into by Group entities in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchanges rates as of the final day of each reporting period. Exchange differences arising from the retranslation of unsettled monetary assets and liabilities are recognized immediately in profit or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation for which exchange differences are recognized in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences arising from the retranslation of the foreign operation. Upon the disposal of a foreign operation, the cumulative exchange differences recognized in the foreign exchange reserve relating to such operation up to the date of disposal are transferred to the consolidated statement of profit or loss and other comprehensive income as part of the gain or loss recognized upon such disposal.
Changes in accounting policies	Changes in accounting policies The accounting policies adopted in the preparation of these unaudited interim condensed consolidated financial statements are consistent with those adopted for the preparation of the consolidated financial statements as of June 30, 2021.
Revisions to previously issued unaudited interim condensed consolidated statements of cash flows	Revisions to previously issued unaudited interim condensed consolidated statements of cash flows The Group has revised the figures presented in our unaudited interim condensed consolidated statements of cash flows as of December 31, 2020. Based on their nature, we changed certain amounts previously shown as short-term investments to cash equivalents and the reporting of the purchases of own shares from investment activities to financing activities. The impact of these changes was considered non-material and is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, 2020 ​ Previously ​ ​ ​ ​ reported ​ Adjustments ​ As revised INVESTMENT ACTIVITIES Proceeds from sales of financial assets 12,732,709 (12,732,709) — Investment in financial assets — (2,630,731) (2,630,731) Purchase of own shares (1,608,560) 1,608,560 — Net cash flows generated (used in) by investing activities 11,124,149 (13,754,880) (2,630,731) ​ ​ ​ ​ ​ ​ ​ FINANCING ACTIVITIES Purchase of own shares — (1,608,560) (1,608,560) Net cash flows used in by financing activities — (1,608,560) (1,608,560) ​ ​ ​ ​ ​ ​ ​ Net increase (decrease) in cash and cash equivalents (8,303,787) (15,363,440) (23,667,227) ​ ​ ​ ​ ​ ​ ​ Inflation effects on cash and cash equivalents (403,950) (1,251,193) (1,655,143) ​ ​ ​ ​ ​ ​ ​ Cash and cash equivalents as of beginning of the period 27,159,421 15,363,440 42,522,861 Effect of exchange rate changes on cash and equivalents 678,522 1,251,193 1,929,715 Cash and cash equivalents as of the end of the period 19,130,206 — 19,130,206

ACCOUNTING STANDARDS AND BASI_3

ACCOUNTING STANDARDS AND BASIS OF PRESENTATION (Tables)	6 Months Ended
	Dec. 31, 2021
ACCOUNTING STANDARDS AND BASIS OF PREPARATION
Summary of revisions to previously issued unaudited interim condensed consolidated statements of cash flows	​ ​ ​ ​ ​ ​ ​ ​ ​ As of December 31, 2020 ​ Previously ​ ​ ​ ​ reported ​ Adjustments ​ As revised INVESTMENT ACTIVITIES Proceeds from sales of financial assets 12,732,709 (12,732,709) — Investment in financial assets — (2,630,731) (2,630,731) Purchase of own shares (1,608,560) 1,608,560 — Net cash flows generated (used in) by investing activities 11,124,149 (13,754,880) (2,630,731) ​ ​ ​ ​ ​ ​ ​ FINANCING ACTIVITIES Purchase of own shares — (1,608,560) (1,608,560) Net cash flows used in by financing activities — (1,608,560) (1,608,560) ​ ​ ​ ​ ​ ​ ​ Net increase (decrease) in cash and cash equivalents (8,303,787) (15,363,440) (23,667,227) ​ ​ ​ ​ ​ ​ ​ Inflation effects on cash and cash equivalents (403,950) (1,251,193) (1,655,143) ​ ​ ​ ​ ​ ​ ​ Cash and cash equivalents as of beginning of the period 27,159,421 15,363,440 42,522,861 Effect of exchange rate changes on cash and equivalents 678,522 1,251,193 1,929,715 Cash and cash equivalents as of the end of the period 19,130,206 — 19,130,206

INFORMATION ABOUT COMPONENTS _3

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Tables)	6 Months Ended
	Dec. 31, 2021
INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
Schedule of cash and cash equivalents	​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Cash at bank and on hand ​ 35,966,810 ​ 28,327,569 Money market funds ​ 399,321 ​ 7,718,544 ​ 36,366,131 36,046,113
Schedule of other financial assets	​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Current Restricted short-term deposits 245,293 425,976 US Treasury bills ​ 1,885,553 ​ 7,885,937 Other investments 1,476,793 2,849,485 ​ 3,607,639 11,161,398 ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Non-current Shares of Bioceres S.A. 398,567 355,251 Other investments 470,465 742,211 ​ 869,032 1,097,462
Schedule of trade receivables	​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Current ​ ​ ​ ​ Trade debtors ​ 106,971,920 ​ 87,709,287 Allowance for impairment of trade debtors (6,405,009) (5,858,503) Shareholders and other related parties (Note 15) 444,095 — Allowance for credit notes to be issued (1,848,700) (2,987,398) Trade debtors - Joint ventures and associates (Note 15) 1,741,964 221,048 Deferred checks 18,380,786 9,699,738 ​ ​ 119,285,056 88,784,172 ​ ​ ​ ​ ​ Non-current ​ ​ ​ ​ Trade debtors ​ 121,234 ​ 135,739 ​ 121,234 ​ 135,739
Schedule of other receivables	​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Current Taxes 8,131,277 6,048,533 Other receivables - Other related parties (Note 15) 1,441 1,547 Other receivables - Parents companies and related parties to Parents (Note 15) — 770,549 Other receivables - Joint ventures and associates (Note 15) 2,679,918 2,219,863 Prepayments to suppliers 4,683,139 1,646,614 Prepayments to suppliers - Shareholders and other related parties (Note 15) 127,726 132,625 Reimbursements over exports 10,548 10,547 Prepaid expenses and other receivables 120,011 1,021 Loans receivables 230,000 230,000 Miscellaneous 271,690 92,406 ​ 16,255,750 11,153,705 ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Non-current ​ ​ Taxes 171,237 862,771 Reimbursements over exports 1,639,408 1,680,371 ​ 1,810,645 2,543,142
Schedule of inventories	​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Seeds 1,047,603 404,774 Resale products 31,157,840 21,368,521 Manufactured products 14,169,831 10,902,683 Goods in transit 1,287,904 1,169,303 Supplies 10,209,965 6,320,594 Agricultural products 31,031,179 21,984,626 Allowance for obsolescence (1,595,610) (1,112,950) ​ ​ 87,308,712 ​ 61,037,551 ​ ​ ​ ​ ​ Net of agricultural products 56,277,533 39,052,925
Schedule of changes in biological assets	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Soybean ​ Corn Wheat Barley HB4 Soy HB4 Wheat Total Beginning of the period ​ 54,162 ​ 27,646 ​ 22,311 ​ 3,071 ​ — ​ 2,208,648 ​ 2,315,838 Initial recognition and changes in the fair value of biological assets — — 292,692 141,899 — 1,708,237 2,142,828 Costs incurred during the period 378,530 649,680 172,957 81,661 1,099,241 33,153,682 35,535,751 Exchange differences 6,622 3,379 2,726 4,039 — 58,841 75,607 Decrease due to harvest — — (490,686) (230,670) — (31,205,748) (31,927,104) Period ended December 31, 2021 439,314 680,705 — — 1,099,241 5,923,660 8,142,920 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Soybean Corn Wheat Barley HB4 Soy HB4 Wheat Total Beginning of the period 105,101 271,754 45,639 34,050 ​ — 509,184 ​ 965,728 Initial recognition and changes in the fair value of biological assets 174,578 129,785 239,266 25,377 ​ (149,702) 564,889 ​ 984,193 Costs incurred during the period 259,760 442,922 254,909 45,490 ​ 10,371,418 4,667,032 ​ 16,041,531 Exchange differences (371,625) (80,335) (28,376) (9,251) ​ (844,644) (378,411) ​ (1,712,642) Decrease due to harvest / disposals (87,982) (110,192) (135,089) (28,504) ​ — (5,362,694) ​ (5,724,461) Period ended December 31, 2020 79,832 653,934 376,349 67,162 ​ 9,377,072 — ​ 10,554,349
Schedule of property plant and equipment	​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Gross carrying amount 67,386,521 63,974,402 Accumulated depreciation (18,439,966) (16,019,806) Net carrying amount 48,946,555 47,954,596
Schedule of net carrying amount	​ ​ ​ ​ ​ ​ ​ ​ Net carrying ​ Net carrying ​ ​ amount ​ amount Class 12/31/2021 06/30/2021 Office equipment ​ 244,773 ​ 288,920 Vehicles ​ 2,387,064 ​ 1,835,634 Equipment and computer software 142,803 67,105 Fixtures and fittings 3,501,808 2,967,431 Machinery and equipment 5,493,935 5,125,728 Land and buildings 35,112,872 35,674,513 Buildings in progress 2,063,300 1,995,265 Total 48,946,555 47,954,596
Schedule of gross carrying amount	1. Gross carrying amount as of December 31, 2021 is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross carrying amount ​ ​ As of the ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ beginning ​ ​ ​ ​ ​ ​ ​ Foreign ​ ​ ​ As of the ​ ​ of the ​ ​ ​ ​ ​ ​ ​ currency ​ ​ ​ end of the Class period Additions Transfers Disposals translation Revaluation period Office equipment ​ 762,825 ​ 17,009 ​ (55,698) ​ — ​ 69,188 ​ — ​ 793,324 Vehicles ​ 3,512,217 ​ 715,492 ​ 55,698 ​ (218,344) ​ 258,800 ​ — ​ 4,323,863 Equipment and computer software ​ 592,126 ​ 101,156 ​ — ​ (49,944) ​ 55,471 ​ — ​ 698,809 Fixtures and fittings ​ 5,637,943 ​ — ​ 356,109 ​ (15) ​ 821,362 ​ — ​ 6,815,399 Machinery and equipment 9,987,811 ​ 371,583 ​ 68,805 (41,468) 1,033,450 — 11,420,181 Land and buildings 41,486,215 ​ — ​ 168,569 — 4,099,357 (4,482,496) 41,271,645 Buildings in progress 1,995,265 ​ 551,106 ​ (593,483) (127,338) 237,750 — 2,063,300 Total 63,974,402 ​ 1,756,346 ​ — (437,109) 6,575,378 (4,482,496) 67,386,521 3. Gross carrying amount as of December 31, 2020, is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross carrying amount ​ ​ As of the ​ ​ ​ ​ ​ Foreign ​ ​ ​ As of the ​ ​ beginning ​ ​ ​ ​ ​ currency ​ ​ ​ end of Class of period Additions Disposals translation Revaluation period Office equipment ​ 579,882 ​ 42,546 ​ (5,103) ​ 1,474 ​ — ​ 618,799 Vehicles ​ 2,977,542 ​ 898,190 ​ (189,537) ​ 33,791 ​ — ​ 3,719,986 Equipment and computer software ​ 465,679 ​ 37,882 ​ — ​ 3,477 ​ — ​ 507,038 Fixtures and fittings ​ 5,480,431 ​ 1,506 ​ — ​ (32,276) ​ — ​ 5,449,661 Machinery and equipment 9,054,701 267,275 — (170,499) — 9,151,477 Land and buildings 34,698,618 57,252 — 118,430 (189,731) 34,684,569 Buildings in progress 1,270,539 451,324 — (4,188) — 1,717,675 Total 54,527,392 1,755,975 (194,640) (49,791) (189,731) 55,849,205
Schedule of accumulated depreciation	2. Accumulated depreciation as of December 31, 2021 is as follows ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Depreciation ​ ​ Accumulated ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ as of the ​ ​ ​ ​ ​ Foreign ​ ​ ​ Accumulated ​ ​ beginning of ​ ​ ​ Of the ​ currency ​ ​ ​ as of the end Class the period Disposals period translation Revaluation of period Office equipment ​ 473,905 ​ — ​ 23,583 ​ 51,063 ​ — ​ 548,551 Vehicles ​ 1,676,583 ​ (196,985) ​ 413,229 ​ 43,972 ​ — ​ 1,936,799 Equipment and computer software ​ 525,021 ​ (49,631) ​ 48,637 ​ 31,979 ​ — ​ 556,006 Fixtures and fittings ​ 2,670,512 ​ — ​ 327,792 ​ 315,287 ​ — ​ 3,313,591 Machinery and equipment 4,862,083 (4,492) 516,171 552,484 — 5,926,246 Land and buildings 5,811,702 — 339,376 700,325 (692,630) 6,158,773 Total 16,019,806 (251,108) 1,668,788 1,695,110 (692,630) 18,439,966 4. Accumulated depreciation as of December 31, 2020, is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Depreciation ​ ​ Accumulated ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ as of the ​ ​ ​ ​ ​ Foreign ​ ​ ​ Accumulated ​ ​ beginning of ​ ​ ​ Of the ​ currency ​ ​ ​ as of the end Class period Disposals period translation Revaluation of period Office equipment ​ 391,602 ​ (2,964) ​ 19,750 ​ 702 ​ — ​ 409,090 Vehicles ​ 1,828,087 ​ (117,085) ​ 289,400 ​ (2,031) ​ — ​ 1,998,371 Equipment and computer software ​ 433,231 ​ — ​ 20,737 ​ 1,315 ​ — ​ 455,283 Fixtures and fittings 1,801,356 ​ — 169,806 5,607 — 1,976,769 Machinery and equipment 3,605,468 ​ — 291,265 11,406 — 3,908,139 Land and buildings 4,952,542 ​ — 313,579 16,187 (48,917) 5,233,391 Total 13,012,286 ​ (120,049) 1,104,537 33,186 (48,917) 13,981,043
Schedule of intangible assets	​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Gross carrying amount 85,908,018 78,019,203 Accumulated amortization (13,345,000) (10,676,841) Net carrying amount 72,563,018 67,342,362
Schedule of net carrying amount of intangibles	​ ​ ​ ​ ​ ​ ​ ​ Net carrying ​ Net carrying ​ ​ amount ​ amount Class 12/31/2021 06/30/2021 Seed and integrated products ​ ​ ​ HB4 soy and breeding program 29,451,462 27,611,142 Integrated seed products 2,848,985 2,558,220 Crop nutrition ​ ​ ​ Microbiological products 4,721,078 3,996,657 Other intangible assets ​ ​ ​ Trademarks and patents 7,330,948 6,923,256 Software 2,261,197 1,849,041 Customer loyalty 20,949,348 19,404,046 RG/RS/OX Wheat ​ 5,000,000 ​ 5,000,000 Total 72,563,018 67,342,362
Schedule of gross carrying amounts of intangibles	1. Gross carrying amount as of December 31, 2021 is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross carrying amount ​ ​ As of the ​ ​ ​ Foreign ​ As of the ​ ​ beginning of ​ ​ ​ currency ​ end of the Class the period Additions translation period Seed and integrated products ​ ​ ​ ​ ​ ​ ​ ​ HB4 soy and breeding program ​ 27,611,142 ​ 1,840,320 ​ — ​ 29,451,462 Integrated seed products ​ 2,558,220 ​ — ​ 290,765 ​ 2,848,985 Crop nutrition ​ ​ ​ ​ ​ ​ ​ ​ Microbiological products 6,037,680 584,924 ​ 648,526 7,271,130 Other intangible assets ​ ​ ​ ​ ​ ​ ​ Trademarks and patents 9,824,171 — ​ 1,129,486 10,953,657 Software 3,784,593 346,268 ​ 508,279 4,639,140 Customer loyalty 23,203,397 — ​ 2,540,247 25,743,644 RG/RS/OX Wheat ​ 5,000,000 ​ — ​ — ​ 5,000,000 Total 78,019,203 2,771,512 ​ 5,117,303 85,908,018 3. Gross carrying amount as of December 31, 2020 is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross ​ ​ As ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ beginning ​ ​ ​ ​ ​ Foreign currency ​ As of the end of Class of period Additions Transfers translation period Seed and integrated products ​ ​ ​ HB4 soy and breeding program 1 7,345,923 ​ 19,063,357 ​ (186,804) ​ 609 ​ 26,223,085 Integrated seed products ​ 2,296,955 ​ — ​ — ​ 7,537 ​ 2,304,492 Crop nutrition ​ ​ ​ ​ Microbiological products 3,867,593 922,937 ​ — 21,369 4,811,899 Other intangible assets ​ ​ ​ ​ ​ Trademarks and patents 8,432,746 — ​ — 27,672 8,460,418 Software 2,088,929 502,137 ​ 186,804 5,092 2,782,962 Customer loyalty 18,800,691 — ​ — 61,693 18,862,384 GLA/ARA safflower ​ — ​ 2,931,699 ​ — ​ — ​ 2,931,699 Total 42,832,837 23,420,130 ​ — 123,972 66,376,939 ​ (1)
Schedule of accumulated amortization of intangibles	2. Accumulated amortization as of December 31, 2021 is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amortization ​ ​ Accumulated ​ ​ ​ Foreign ​ Accumulated as ​ ​ as of beginning ​ ​ ​ currency ​ of the end of the Class of the period Of the period translation period Crop nutrition ​ ​ ​ ​ Microbiological products ​ 2,041,023 ​ 259,522 ​ 249,507 ​ 2,550,052 Other intangible assets ​ ​ ​ ​ ​ ​ ​ Trademarks and patents ​ 2,900,915 ​ 368,581 ​ 353,213 ​ 3,622,709 Software 1,935,552 212,148 ​ 230,243 2,377,943 Customer loyalty 3,799,351 535,747 ​ 459,198 4,794,296 Total 10,676,841 1,375,998 ​ 1,292,161 13,345,000 4. Accumulated amortization as of December 31, 2020 is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amortization ​ ​ Accumulated as ​ ​ Foreign ​ Accumulated ​ ​ of beginning of ​ ​ ​ currency ​ as of the end Class period Of the period translation of period Crop nutrition ​ Microbiological products 1,363,962 229,417 5,407 1,598,786 Other intangible assets ​ ​ ​ Trademarks and patents 2,057,964 279,016 6,754 2,343,734 Software 1,401,964 200,277 3,695 1,605,936 Customer loyalty 2,675,483 362,738 8,779 3,047,000 Total 7,499,373 1,071,448 24,635 8,595,456
Schedule of carrying amount of goodwill	​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Rizobacter Argentina S.A. 25,080,278 22,277,336 Bioceres Crops S.A. ​ 6,737,752 ​ 6,003,780 Insumos Agroquímicos S.A. ​ 470,090 ​ 470,090 ​ 32,288,120 28,751,206
Schedule of trade and other payable	​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Current ​ ​ ​ ​ Trade creditors 82,253,229 51,389,515 Shareholders and other related parties (Note 15) 53,661 52,864 Trade creditors - Parent company (Note 15) 182,812 193,718 Trade creditors - Joint ventures and associates (Note 15) 21,113,841 17,669,027 Taxes 2,138,995 2,556,945 Miscellaneous 273,704 229,339 ​ 106,016,242 72,091,408
Schedule of borrowings	​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Current ​ ​ ​ ​ Bank overdrafts — 32,838 Bank borrowings 36,004,973 33,684,287 Corporate bonds 5,358,525 24,742,752 Trust debt securities ​ 3,080,286 ​ 3,470,448 Net loans payables- Parents companies and related parties to Parents (Note 15) 3,697,715 3,578,921 Other finance debt ​ 89,164 ​ — Subordinated loan ​ — ​ 11,276,611 ​ 48,230,663 76,785,857 Non-current ​ ​ Bank borrowings 8,656,385 4,161,827 Corporate bonds 74,004,867 37,826,641 Net loans payables- Parents companies and related parties to Parents (Note 15) 6,000,000 6,000,000 Trust debt securities 2,076,976 — ​ ​ 90,738,228 ​ 47,988,468
Schedule of carrying value of borrowings	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 12/31/2021 ​ 06/30/2021 ​ ​ Amortized cost ​ Fair value ​ Amortized cost ​ Fair value Current ​ ​ ​ ​ ​ ​ ​ ​ Bank borrowings 36,004,973 34,440,750 33,684,287 32,770,615 Corporate Bonds 5,358,525 5,322,676 24,742,752 24,085,087 ​ ​ ​ ​ ​ ​ ​ ​ ​ Non-current ​ ​ Bank borrowings 8,656,385 7,985,438 4,161,827 3,864,666 Corporate Bonds 74,004,867 68,109,433 37,826,641 32,656,097
Schedule of employee benefits and social security	​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Current ​ ​ ​ ​ Salaries, accrued incentives, vacations and social security 6,201,169 4,243,585 Key management personnel (Note 15) ​ 270,909 ​ 436,493 ​ ​ 6,472,078 ​ 4,680,078

INFORMATION ABOUT COMPONENTS _4

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Tables)	6 Months Ended
	Dec. 31, 2021
INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
Schedule of revenue	​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 Sale of goods and services 157,538,626 88,616,572 Royalties 1,129,024 1,492,026 ​ 158,667,650 90,108,598
Schedule of cost of sales	​ ​ ​ ​ ​ ​ Item 12/31/2021 12/31/2020 Inventories as of the beginning of the period 39,052,925 29,338,548 Purchases of the period 102,342,174 56,271,944 Production costs 7,581,570 5,514,975 Foreign currency translation 516,306 (1,283,574) Subtotal 149,492,975 89,841,893 Inventories as of the end of the period 1 (56,277,533) (41,655,409) Cost of sales 93,215,442 48,186,484 ​ (1) Net of agricultural products.
Schedule of R&D classified by nature	​ ​ ​ ​ ​ ​ ​ Research and Research and ​ ​ development ​ development ​ expenses expenses Item 12/31/2021 12/31/2020 Amortization of intangible assets 604,462 508,433 Import and export expenses 1,685 9,322 Depreciation of property, plant and equipment 213,837 69,860 Employee benefits and social securities 685,412 496,967 Maintenance 25,702 14,045 Energy and fuel 24,659 17,564 Supplies and materials 726,899 460,272 Mobility and travel 38,564 4,668 Share-based incentives 30,099 — Professional fees and outsourced services 137,674 67,550 Professional fees related parties ​ 296,967 ​ 466,144 Office supplies 2,842 2,467 Information technology expenses ​ 6,039 ​ 9,992 Insurance 12,598 8,326 Depreciation of leased assets ​ 2,523 ​ 1,279 Miscellaneous 5,612 2,143 Total 2,815,574 2,139,032 ​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 R&D capitalized (Note 6.8) 2,425,244 1,556,367 R&D profit and loss 2,815,574 2,139,032 Total 5,240,818 3,695,399
Schedule of expenses classified by nature and function	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Selling, ​ ​ ​ ​ general and ​ ​ ​ ​ Production ​ administrative ​ Total Item ​ costs ​ expenses ​ 12/31/2021 Amortization of intangible assets — ​ 771,536 ​ 771,536 Analysis and storage 26,537 ​ 69,502 ​ 96,039 Commissions and royalties 547,364 ​ 1,181,465 ​ 1,728,829 Import and export expenses 61,209 ​ 560,934 ​ 622,143 Depreciation of property, plant and equipment 655,067 ​ 799,884 ​ 1,454,951 Depreciation of leased assets ​ 246,942 ​ 251,767 ​ 498,709 Impairment of receivables — ​ 815,929 ​ 815,929 Freight and haulage 311,416 ​ 4,457,096 ​ 4,768,512 Employee benefits and social securities 3,265,750 ​ 11,033,554 ​ 14,299,304 Maintenance 400,778 ​ 570,294 ​ 971,072 Energy and fuel 233,958 ​ 24,908 ​ 258,866 Supplies and materials 351,410 ​ 570,762 ​ 922,172 Mobility and travel 7,361 ​ 696,370 ​ 703,731 Publicity and advertising — ​ 2,247,729 ​ 2,247,729 Contingencies — ​ 65,598 ​ 65,598 Share-based incentives ​ — ​ 843,308 ​ 843,308 Professional fees and outsourced services 587,370 ​ 3,075,667 ​ 3,663,037 Professional fees related parties — ​ 48,934 ​ 48,934 Office supplies 89,670 ​ 198,228 ​ 287,898 Insurance 36,328 ​ 556,441 ​ 592,769 Information technology expenses — ​ 817,032 ​ 817,032 Obsolescence 740,264 ​ — ​ 740,264 Taxes 19,398 ​ 5,230,416 ​ 5,249,814 Miscellaneous 748 ​ 110,407 ​ 111,155 Total 7,581,570 ​ 34,997,761 ​ 42,579,331 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Selling, ​ ​ ​ ​ ​ general and ​ ​ ​ ​ Production ​ administrative ​ Total Item ​ costs ​ expenses ​ 12/31/2020 Amortization of intangible assets — 563,015 563,015 Analysis and storage 18,651 46,251 64,902 Commissions and royalties 767,326 287,445 1,054,771 Import and export expenses 29,128 434,113 463,241 Depreciation of property, plant and equipment 560,806 473,871 1,034,677 Depreciation of leased assets ​ 125,226 ​ 160,979 ​ 286,205 Impairment of receivables — 126,593 126,593 Freight and haulage 248,785 2,023,017 2,271,802 Employee benefits and social securities 2,260,596 7,010,150 9,270,746 Maintenance 282,937 259,182 542,119 Energy and fuel 156,666 23,848 180,514 Supplies and materials 187,315 58,212 245,527 Mobility and travel 1,593 369,382 370,975 Publicity and advertising — 1,062,884 1,062,884 Contingencies — 52,441 ​ 52,441 Share-based incentives ​ — ​ 636,519 ​ 636,519 Professional fees and outsourced services 335,681 4,040,404 4,376,085 Professional fees related parties — 113,888 113,888 Office supplies 89,049 150,121 239,170 Insurance 68,033 392,752 460,785 Information technology expenses 849 530,970 531,819 Obsolescence 365,458 — 365,458 Taxes 16,609 2,431,415 2,448,024 Miscellaneous 267 64,507 64,774 Total 5,514,975 21,311,959 26,826,934
Schedule of financial results	​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 Financial costs ​ ​ ​ ​ Interest expenses with the Parents (Note 15) (415,812) (634,128) Interest expenses (5,439,593) (9,043,815) Financial commissions (907,660) (964,237) ​ (6,763,065) (10,642,180) ​ ​ ​ ​ ​ Other financial results ​ ​ ​ Exchange differences generated by assets 6,355,520 10,714,855 Exchange differences generated by liabilities ​ (11,682,895) ​ (16,991,043) Changes in fair value of financial assets or liabilities and other financial results ​ (1,652,984) ​ (5,466,867) Net gain of inflation effect on monetary items ​ 342,135 ​ 3,752,899 ​ ​ (6,638,224) ​ (7,990,156) ​ ​ ​ ​ ​ Total net financial results (13,401,289) (18,632,336)

TAXATION (Tables)

TAXATION (Tables)	6 Months Ended
	Dec. 31, 2021
TAXATION
Schedule of current tax	​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 Current tax expense (11,916,178) (6,716,736) Deferred tax 5,179,763 875,283 Total ​ (6,736,415) ​ (5,841,453)
Schedule of deferred tax assets and liabilities	​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 Beginning of the period deferred tax (22,421,125) (14,164,930) Charge of the period 5,179,763 875,283 Charge to OCI ​ 1,326,453 ​ 35,204 Conversion difference ​ (2,993,421) ​ (145,175) Total net deferred tax (18,908,330) (13,399,618) ​
Schedule of reconciliation of the statutory tax rate to the effective tax rate	​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 Earning before income tax-rate 14,340,137 1,270,149 Income tax expense by applying tax rate in force in the respective countries (7,314,555) (4,007,409) Share of profit or loss of subsidiaries, joint ventures and associates 269,138 100,552 Stock options charge (180,523) (29,199) Rate change adjustment — (163,269) Non-deductible expenses (315,241) (295,416) Representation expenses (3,039) (10,972) Foreign investment coverage 140,720 248,743 Tax inflation adjustment ​ 1,097,315 ​ (1,197,624) Result of inflation effect on monetary items and other finance results ​ (479,093) ​ (457,537) Others 48,863 (29,322) Income tax expenses (6,736,415) (5,841,453)

EARNINGS PER SHARE (EPS) (Table

EARNINGS PER SHARE (EPS) (Tables)	6 Months Ended
	Dec. 31, 2021
EARNINGS PER SHARE (EPS)
Schedule of earnings per share	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three -month period ended ​ Six -month period ended ​ 12/31/2021 12/31/2020 12/31/2021 12/31/2020 Numerator ​ ​ ​ ​ ​ Profit (loss) for the period (basic EPS) 3,427,093 ​ 648,193 ​ 4,301,230 (6,323,365) Profit (loss) for the period (diluted EPS) 3,427,093 ​ 648,193 ​ 4,301,230 (6,323,365) Denominator ​ ​ ​ ​ ​ ​ Weighted average number of shares (basic EPS) 41,104,331 ​ 38,016,601 ​ 41,104,331 38,016,601 Weighted average number of shares (diluted EPS) 42,403,196 ​ 39,038,280 ​ 42,403,196 38,016,601 ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic profit (loss) attributable to ordinary equity holders of the parent ​ 0.0834 ​ 0.0171 ​ 0.1046 ​ (0.1663) Diluted profit (loss) attributable to ordinary equity holders of the parent 0.0808 ​ 0.0166 ​ 0.1014 (0.1663)

CASH FLOW INFORMATION (Tables)

CASH FLOW INFORMATION (Tables)	6 Months Ended
	Dec. 31, 2021
CASH FLOW INFORMATION
Schedule of significant non-cash transactions related to investing and financing activities	​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 Investment activities ​ ​ ​ ​ Settlement of receivables through PPE contribution ​ — ​ 1,547,543 Investment in-kind in other related parties (Note 15) ​ 437,780 ​ 921,390 Acquisition of assets financed by debt — 7,637,972 Acquisition of assets through issuance of capital ​ — ​ 15,000,000 ​ ​ 437,780 ​ 25,106,905 ​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 Financing activities Acquisition of non-controlling interest in subsidiaries 255,893 — ​ 255,893 —

JOINT VENTURES AND ASSOCIATES (

JOINT VENTURES AND ASSOCIATES (Tables)	6 Months Ended
	Dec. 31, 2021
JOINT VENTURES AND ASSOCIATES
Schedule of investments in joint ventures and associates	​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Assets Synertech Industrias S.A. 30,867,914 27,572,597 Indrasa Biotecnología S.A. 113,821 54,957 Alfalfa Technologies S.R.L. 91,240 97,920 Moolec Science Limited 2,981,982 2,931,699 ​ 34,054,957 30,657,173 ​ ​ ​ ​ ​ ​ Liabilities Trigall Genetics S.A. 616,173 1,278,250 ​ 616,173 1,278,250 ​
Schedule of share of profit or loss of joint ventures and associates	​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 Trigall Genetics S.A. 662,077 (98,280) Synertech Industrias S.A. 319,356 376,635 Moolec Science Limited ​ (114,709) ​ — Indrasa Biotecnología S.A. 52,363 27,332 ​ 919,087 305,687
Schedule of changes in joint ventures and associates investments	​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 As of the beginning of the period 29,378,923 23,103,963 Revaluation of property, plant and equipment (363,848) (11,495) Foreign currency translation 3,504,622 49,996 Share of profit or loss 919,087 305,687 As of the end of the period 33,438,784 23,448,151

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	6 Months Ended
	Dec. 31, 2021
SEGMENT INFORMATION
Schedule of operating results group's reporting segments	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Seed and ​ ​ ​ ​ integrated Crop Crop ​ ​ ​ Period ended December 31, 2021 products ​ protection ​ nutrition ​ Consolidated ​ Revenues from contracts with customers ​ ​ ​ ​ ​ ​ ​ ​ ​ Sale of goods and services 23,767,633 82,062,604 51,708,389 157,538,626 ​ Royalties 1,129,024 ​ ​ 1,129,024 ​ Others ​ ​ ​ ​ ​ ​ ​ ​ ​ Government grants ​ 805 ​ — ​ — ​ 805 ​ Initial recognition and changes in the fair value of biological assets 1,033,753 845,387 263,688 2,142,828 ​ Changes in the net realizable value of agricultural products after harvest ​ (821,078) ​ (304,522) ​ (116,585) ​ (1,242,185) ​ Total 25,110,137 82,603,469 51,855,492 159,569,098 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Cost of sales (8,988,420) (57,480,257) (26,746,765) (93,215,442) ​ Gross profit per segment 16,121,717 25,123,212 25,108,727 66,353,656 ​ % Gross margin ​ 64 % 30 % 48 % 42 % ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Seed and ​ ​ ​ ​ integrated Crop Crop ​ ​ ​ Period ended December 31, 2020 products ​ protection ​ nutrition ​ Consolidated ​ Revenues from contracts with customers ​ ​ ​ ​ ​ ​ ​ ​ ​ Sale of goods and services 19,191,676 48,577,062 20,847,834 88,616,572 ​ Royalties 1,492,026 ​ ​ 1,492,026 ​ Others ​ ​ ​ ​ ​ Government grants 1,160 — — 1,160 ​ Initial recognition and changes in the fair value of biological assets ​ 470,789 ​ 119,039 ​ 394,365 ​ 984,193 ​ Total 21,155,651 48,696,101 21,242,199 91,093,951 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Cost of sales (8,705,712) ​ (28,703,147) ​ (10,777,625) ​ (48,186,484) ​ Gross profit per segment 12,449,939 19,992,954 10,464,574 42,907,467 ​ % Gross margin ​ 59 % 41 % 49 % 47 %

FINANCIAL INSTRUMENTS - RISK _2

FINANCIAL INSTRUMENTS - RISK MANAGEMENT (Tables)	6 Months Ended
	Dec. 31, 2021
FINANCIAL INSTRUMENTS - RISK MANAGEMENT
Schedule of financial assets by category	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Mandatorily measured at fair ​ ​ Amortized cost ​ value through profit or loss Financial asset 12/31/2021 06/30/2021 12/31/2021 06/30/2021 Cash and cash equivalents 35,966,810 28,327,569 399,321 7,718,544 Other financial assets 1,114,325 1,523,438 3,362,346 10,735,422 Trade receivables 119,406,290 88,919,911 — — Other receivables (*) 4,833,005 5,005,283 — — Total 161,320,430 123,776,201 3,761,667 18,453,966 ​ (*) Advances expenses and tax balances are not included.
Schedule financial liabilities by category	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Mandatorily measured at fair ​ ​ Amortized cost ​ value through profit or loss Financial liability 12/31/2021 06/30/2021 12/31/2021 06/30/2021 Trade and other payables 106,016,242 72,091,408 — — Borrowings 138,879,727 ​ 124,774,325 89,164 — Convertible notes ​ 48,890,332 ​ 48,664,012 ​ — ​ — Lease liability ​ 1,205,745 ​ 1,140,717 ​ — ​ — Employee benefits and social security 6,472,078 4,680,078 — — Consideration for acquisition of assets 12,443,071 11,790,533 — — Total 313,907,195 263,141,073 89,164 —
Schedule of fair value by hierarchy	​ ​ ​ ​ ​ ​ ​ ​ Measurement at fair value at 12/31/2021 Level 1 Level 2 Level 3 Financial assets at fair value ​ ​ ​ ​ ​ ​ Mutual funds ​ 399,321 ​ — ​ — US Treasury bills ​ 1,885,553 ​ — ​ — Other investments 1,476,793 — — ​ ​ ​ ​ ​ ​ ​ Financial liabilities at fair value ​ ​ ​ Other finance debt ​ — ​ 89,164 ​ — ​ ​ ​ ​ ​ ​ ​ Measurement at fair value at 06/30/2021 Level 1 Level 2 Level 3 Financial assets at fair value ​ ​ ​ ​ ​ ​ Mutual funds ​ 7,718,544 ​ — ​ — US Treasury bills 7,885,937 — — Other investments ​ 2,110,414 ​ 739,071 ​ —

SHAREHOLDERS AND OTHER RELATE_2

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS (Tables)	6 Months Ended
	Dec. 31, 2021
SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS
Schedule of transactions between the group and related parties, and the related balances owed	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amount of transactions for the period ended Party Transaction type 12/31/2021 12/31/2020 Joint ventures and associates Sales and services 10,839,406 2,920,262 Joint ventures and associates Purchases of goods and services (29,026,646) (9,763,160) Joint ventures and associates Net loans granted — 18,409 Key management personnel Salaries, social security benefits and other benefits (1,677,312) (1,716,413) Key management personnel Net loans cancelled — (603,093) Key management personnel Interest gain — (8,879) Shareholders and other related parties Sales of goods and services 313,432 161,792 Shareholders and other related parties Purchases of goods and services (2,441,710) (399,888) Shareholders and other related parties In-kind contributions 437,780 921,390 Parent company and related parties to Parent (Note 7.5) Interest expenses (415,812) (634,128) Total (21,970,862) (9,103,708) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amounts receivable from related parties Party Transaction type 12/31/2021 06/30/2021 Parent company and related parties to Parent Other receivables — 770,549 Shareholders and other related parties Trade debtors 444,095 — Other receivables - Other related parties Other receivables 129,167 134,172 Joint ventures and associates Trade debtors 1,741,964 221,048 Joint ventures and associates Other receivables 2,679,918 2,219,863 Total ​ ​ 4,995,144 3,345,632 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amounts payable to related parties Party Transaction type 12/31/2021 06/30/2021 Parent company and related parties to Parent ​ Trade creditors ​ (182,812) ​ (193,718) Parent company and related parties to Parent ​ Net loans payables ​ (9,697,715) ​ (9,578,921) Key management personnel Salaries, social security benefits and other benefits (270,909) (436,493) Shareholders and other related parties Trade and other payables (53,661) (52,864) Joint ventures and associates Trade creditors (21,113,841) (17,669,027) Total ​ ​ (31,318,938) (27,931,023)

KEY MANAGEMENT PERSONNEL COMP_2

KEY MANAGEMENT PERSONNEL COMPENSATION (Tables)	6 Months Ended
	Dec. 31, 2021
KEY MANAGEMENT PERSONNEL COMPENSATION
Schedule of compensation of directors and other members of key management personnel	​ ​ ​ ​ ​ ​ ​ 12/31/2021 12/31/2020 ​ ​ ​ ​ ​ Salaries, social security and other benefits 803,905 1,079,894 Share-based incentives ​ 873,407 ​ 636,519 Total 1,677,312 1,716,413

SHARE-BASED PAYMENTS (Tables)

SHARE-BASED PAYMENTS (Tables)	6 Months Ended
	Dec. 31, 2021
SHARE-BASED PAYMENTS
Schedule of fair value of the share options and the factors used for its calculation	​ ​ ​ ​ ​ ​ ​ Directors and Junior Factor ​ Sr. Management ​ Management Weighted average fair value of shares $5.42 $13.98 Exercise price $4.55 $5.55 Weighted average expected volatility (*) 29.69% 42.18% Dividend rate 0% 0% Weighted average risk-free interest rate 1.66% 1.17% Weighted average expected life 9.89 years 9.22 years Weighted average fair value of stock options at measurement date $2.47 $10.1
Schedule of weighted average amount and exercise price and the movements of the stock options of executives and directors	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 12/31/2021 ​ 12/30/2020 ​ ​ Number of ​ Exercise ​ Number of ​ Exercise ​ options price options price At the beginning 1,166,667 $ 4.55 1,200,000 $ 4.55 Granted during the period 93,600 $ 5.55 — ​ — Annulled during the period — ​ — — ​ — Exercised during the period (2,000) $ 5.55 — ​ — Expired during the period — ​ — — ​ — Effective at period(*) 1,258,267 $ 4.62 1,200,000 $ 4.55 (*)

LEASE (Tables)

LEASE (Tables)	6 Months Ended
	Dec. 31, 2021
LEASE
Reconciliation of right of use leased assets and lease liability from beginning of year to end of year	​ ​ ​ ​ ​ ​ Right-of-use leased asset 12/31/2021 06/30/2021 Book value at the beginning of the period 3,688,150 2,369,326 Additions of the period 612,579 913,321 Exchange differences ​ (156,673) ​ 405,503 Book value at the end of the year 4,144,056 3,688,150 ​ ​ ​ ​ ​ Depreciation 12/31/2021 06/30/2021 Book value at the beginning of the period ​ 2,360,490 ​ 1,254,729 Exchange differences (206,274) 278,441 Depreciation of the period 501,232 827,320 Accumulated depreciation at the end of the period 2,655,448 2,360,490 Total 1,488,608 1,327,660 ​ ​ ​ ​ ​ ​ Lease liability 12/31/2021 06/30/2021 Book value at the beginning of the period 1,140,717 1,109,812 Additions of the year 396,205 259,427 Interest expenses, exchange differences and inflation effects 162,276 500,442 Payments of the period (493,453) (728,964) Total 1,205,745 1,140,717 ​ ​ ​ ​ ​ ​ Lease Liabilities 12/31/2021 06/30/2021 Non-current 570,505 390,409 Current 635,240 750,308 Total 1,205,745 1,140,717
Schedule of right-of-use leased assets	​ ​ ​ ​ ​ ​ ​ 12/31/2021 06/30/2021 Machinery and equipment 742,417 661,544 Vehicles 1,007,824 1,061,184 Equipment and computer software 668,160 582,101 Land and buildings 1,725,655 1,383,321 ​ 4,144,056 3,688,150

GENERAL INFORMATION - (Details)

GENERAL INFORMATION - (Details)	Dec. 31, 2021country
Business information
Number of countries with agricultural inputs	30

ACCOUNTING STANDARDS AND BASI_4

ACCOUNTING STANDARDS AND BASIS OF PREPARATION - (Details)	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020	Jun. 30, 2020
Acquisition-date fair value of total consideration transferred
Conversion factor to calculate inflation adjustment	582.4575	483.6049	385.8826	321.9738

ACCOUNTING STANDARDS AND BASI_5

ACCOUNTING STANDARDS AND BASIS OF PRESENTATION - Revision of prior period financials (Details) - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
INVESTMENT ACTIVITIES
Proceeds from sales of financial assets	$ 8,657,999
Investment in financial assets	(482,849)	$ (2,630,731)
Net cash flows generated (used in) by investing activities	3,966,879	(12,195,310)
FINANCING ACTIVITIES
Purchase of own shares		(1,608,560)
Net cash flows generated by financing activities	17,777,727	12,173,742
Net increase (decrease) in cash and cash equivalents	1,877,098	(23,667,227)
Inflation effects on cash and cash equivalents	(3,592,117)	(1,655,143)
Cash and cash equivalents as of beginning of the period	36,046,113	42,522,861
Effect of exchange rate changes on cash and equivalents	2,035,037	1,929,715
Cash and cash equivalents as of the end of the period	$ 36,366,131	19,130,206
Changes in accounting treatment of short-term investments and purchases of treasury shares
INVESTMENT ACTIVITIES
Investment in financial assets		(2,630,731)
Net cash flows generated (used in) by investing activities		(2,630,731)
FINANCING ACTIVITIES
Purchase of own shares		(1,608,560)
Net cash flows generated by financing activities		(1,608,560)
Net increase (decrease) in cash and cash equivalents		(23,667,227)
Inflation effects on cash and cash equivalents		(1,655,143)
Cash and cash equivalents as of beginning of the period		42,522,861
Effect of exchange rate changes on cash and equivalents		1,929,715
Cash and cash equivalents as of the end of the period		19,130,206
Previously reported | Changes in accounting treatment of short-term investments and purchases of treasury shares
INVESTMENT ACTIVITIES
Proceeds from sales of financial assets		12,732,709
Purchase of own shares		(1,608,560)
Net cash flows generated (used in) by investing activities		11,124,149
FINANCING ACTIVITIES
Net increase (decrease) in cash and cash equivalents		(8,303,787)
Inflation effects on cash and cash equivalents		(403,950)
Cash and cash equivalents as of beginning of the period		27,159,421
Effect of exchange rate changes on cash and equivalents		678,522
Cash and cash equivalents as of the end of the period		19,130,206
Adjustments | Changes in accounting treatment of short-term investments and purchases of treasury shares
INVESTMENT ACTIVITIES
Proceeds from sales of financial assets		(12,732,709)
Investment in financial assets		(2,630,731)
Purchase of own shares		1,608,560
Net cash flows generated (used in) by investing activities		(13,754,880)
FINANCING ACTIVITIES
Purchase of own shares		(1,608,560)
Net cash flows generated by financing activities		(1,608,560)
Net increase (decrease) in cash and cash equivalents		(15,363,440)
Inflation effects on cash and cash equivalents		(1,251,193)
Cash and cash equivalents as of beginning of the period		15,363,440
Effect of exchange rate changes on cash and equivalents		$ 1,251,193

INFORMATION ABOUT COMPONENTS _5

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
Cash at bank and on hand	$ 35,966,810	$ 28,327,569
Money market funds	399,321	7,718,544
Cash and cash equivalents	$ 36,366,131	$ 36,046,113

INFORMATION ABOUT COMPONENTS _6

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Current
Restricted short-term deposit	$ 245,293	$ 425,976
US Treasury bills	1,885,553	7,885,937
Other investments	1,476,793	2,849,485
Other financial assets	3,607,639	11,161,398
Non-current
Shares of Bioceres S.A.	398,567	355,251
Other marketable securities	470,465	742,211
Other financial assets	$ 869,032	$ 1,097,462

INFORMATION ABOUT COMPONENTS _7

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Components of Consolidated Statement of Financial Position
Trade debtors	$ 106,971,920	$ 87,709,287
Allowance for impairment of trade debtors	(6,405,009)	(5,858,503)
Allowance for credit notes to be issued	(1,848,700)	(2,987,398)
Deferred checks	18,380,786	9,699,738
Trade receivables	119,285,056	88,784,172
Trade debtors	121,234	135,739
Non-current Trade receivables	121,234	135,739
Shareholders and other other related parties
Components of Consolidated Statement of Financial Position
Trade debtors	444,095
Joint ventures and associates
Components of Consolidated Statement of Financial Position
Trade debtors	$ 1,741,964	$ 221,048

INFORMATION ABOUT COMPONENTS _8

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Current
Taxes	$ 8,131,277	$ 6,048,533
Prepayments to suppliers	4,683,139	1,646,614
Reimbursements over exports	10,548	10,547
Prepaid expenses and other receivables	120,011	1,021
Loans receivables	230,000	230,000
Miscellaneous	271,690	92,406
Other receivables	16,255,750	11,153,705
Non-current
Taxes	171,237	862,771
Reimbursements over exports	1,639,408	1,680,371
Other receivables	1,810,645	2,543,142
Other receivables - Other related parties
Current
Other receivables	1,441	1,547
Shareholders and other other related parties
Current
Prepayments to suppliers	127,726	132,625
Parent company
Current
Other receivables		770,549
Joint ventures and associates
Current
Other receivables	$ 2,679,918	$ 2,219,863

INFORMATION ABOUT COMPONENTS _9

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Inventory
Goods in transit	$ 1,287,904	$ 1,169,303
Supplies	10,209,965	6,320,594
Agricultural products	31,031,179	21,984,626
Inventories	87,308,712	61,037,551
Net of agricultural products	56,277,533	39,052,925
Seeds
Inventory
Inventories	1,047,603	404,774
Microbiological resale products
Inventory
Inventories	31,157,840	21,368,521
Microbiological products produced
Inventory
Inventories	14,169,831	10,902,683
Allowance for obsolescence
Inventory
Inventories	$ (1,595,610)	$ (1,112,950)

INFORMATION ABOUT COMPONENTS_10

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Biological assets (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Biological assets
Beginning of the period			$ 2,315,838	$ 965,728
Initial recognition and changes in the fair value of biological assets	$ 1,590,925	$ 734,826	2,142,828	984,193
Cost incurred during the period			35,535,751	16,041,531
Exchange differences			75,607	(1,712,642)
Decrease due to harvest / disposals			(31,927,104)	(5,724,461)
End of period	8,142,920	10,554,349	8,142,920	10,554,349
Soybean
Biological assets
Beginning of the period			54,162	105,101
Initial recognition and changes in the fair value of biological assets				174,578
Cost incurred during the period			378,530	259,760
Exchange differences			6,622	(371,625)
Decrease due to harvest / disposals				(87,982)
End of period	439,314	79,832	439,314	79,832
Corn
Biological assets
Beginning of the period			27,646	271,754
Initial recognition and changes in the fair value of biological assets				129,785
Cost incurred during the period			649,680	442,922
Exchange differences			3,379	(80,335)
Decrease due to harvest / disposals				(110,192)
End of period	680,705	653,934	680,705	653,934
Wheat
Biological assets
Beginning of the period			22,311	45,639
Initial recognition and changes in the fair value of biological assets			292,692	239,266
Cost incurred during the period			172,957	254,909
Exchange differences			2,726	(28,376)
Decrease due to harvest / disposals			(490,686)	(135,089)
End of period		376,349		376,349
Barley
Biological assets
Beginning of the period			3,071	34,050
Initial recognition and changes in the fair value of biological assets			141,899	25,377
Cost incurred during the period			81,661	45,490
Exchange differences			4,039	(9,251)
Decrease due to harvest / disposals			(230,670)	(28,504)
End of period		67,162		67,162
HB4 Soy
Biological assets
Beginning of the period			0	0
Initial recognition and changes in the fair value of biological assets				(149,702)
Cost incurred during the period			1,099,241	10,371,418
Exchange differences				(844,644)
End of period	1,099,241	$ 9,377,072	1,099,241	9,377,072
HB4 Wheat
Biological assets
Beginning of the period			2,208,648	509,184
Initial recognition and changes in the fair value of biological assets			1,708,237	564,889
Cost incurred during the period			33,153,682	4,667,032
Exchange differences			58,841	(378,411)
Decrease due to harvest / disposals			(31,205,748)	$ (5,362,694)
End of period	$ 5,923,660		$ 5,923,660

INFORMATION ABOUT COMPONENTS_11

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020	Jun. 30, 2020
Property, plant and equipment
Property, plant and equipment	$ 48,946,555	$ 47,954,596
Gross carrying amount
Property, plant and equipment
Property, plant and equipment	67,386,521	63,974,402	$ 55,849,205	$ 54,527,392
Accumulated depreciation/amortization
Property, plant and equipment
Property, plant and equipment	$ (18,439,966)	$ (16,019,806)	$ (13,981,043)	$ (13,012,286)

INFORMATION ABOUT COMPONENTS_12

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - net carrying amount (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Property, plant and equipment
Property, plant and equipment	$ 48,946,555	$ 47,954,596
Office equipment
Property, plant and equipment
Property, plant and equipment	244,773	288,920
Vehicles
Property, plant and equipment
Property, plant and equipment	2,387,064	1,835,634
Equipment and computer software
Property, plant and equipment
Property, plant and equipment	142,803	67,105
Fixture and fittings
Property, plant and equipment
Property, plant and equipment	3,501,808	2,967,431
Machinery and equipment
Property, plant and equipment
Property, plant and equipment	5,493,935	5,125,728
Land and buildings
Property, plant and equipment
Property, plant and equipment	35,112,872	35,674,513
Buildings in progress
Property, plant and equipment
Property, plant and equipment	$ 2,063,300	$ 1,995,265

INFORMATION ABOUT COMPONENTS_13

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - gross carrying amounts (Details) - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Property, plant and equipment
As of the beginning of period	$ 47,954,596
As of the end of period	48,946,555
Office equipment
Property, plant and equipment
As of the beginning of period	288,920
As of the end of period	244,773
Vehicles
Property, plant and equipment
As of the beginning of period	1,835,634
As of the end of period	2,387,064
Equipment and computer software
Property, plant and equipment
As of the beginning of period	67,105
As of the end of period	142,803
Fixture and fittings
Property, plant and equipment
As of the beginning of period	2,967,431
As of the end of period	3,501,808
Machinery and equipment
Property, plant and equipment
As of the beginning of period	5,125,728
As of the end of period	5,493,935
Land and buildings
Property, plant and equipment
As of the beginning of period	35,674,513
As of the end of period	35,112,872
Buildings in progress
Property, plant and equipment
As of the beginning of period	1,995,265
As of the end of period	2,063,300
Gross carrying amount
Property, plant and equipment
As of the beginning of period	63,974,402	$ 54,527,392
Additions	1,756,346	1,755,975
Disposals	(437,109)	(194,640)
Foreign currency translation	6,575,378	(49,791)
Revaluation	4,482,496	189,731
As of the end of period	67,386,521	55,849,205
Gross carrying amount | Office equipment
Property, plant and equipment
As of the beginning of period	762,825	579,882
Additions	17,009	42,546
Transfers	(55,698)
Disposals		(5,103)
Foreign currency translation	69,188	1,474
As of the end of period	793,324	618,799
Gross carrying amount | Vehicles
Property, plant and equipment
As of the beginning of period	3,512,217	2,977,542
Additions	715,492	898,190
Transfers	55,698
Disposals	(218,344)	(189,537)
Foreign currency translation	258,800	33,791
As of the end of period	4,323,863	3,719,986
Gross carrying amount | Equipment and computer software
Property, plant and equipment
As of the beginning of period	592,126	465,679
Additions	101,156	37,882
Disposals	(49,944)
Foreign currency translation	55,471	3,477
As of the end of period	698,809	507,038
Gross carrying amount | Fixture and fittings
Property, plant and equipment
As of the beginning of period	5,637,943	5,480,431
Additions		1,506
Transfers	356,109
Disposals	(15)
Foreign currency translation	821,362	(32,276)
As of the end of period	6,815,399	5,449,661
Gross carrying amount | Machinery and equipment
Property, plant and equipment
As of the beginning of period	9,987,811	9,054,701
Additions	371,583	267,275
Transfers	68,805
Disposals	(41,468)
Foreign currency translation	1,033,450	(170,499)
As of the end of period	11,420,181	9,151,477
Gross carrying amount | Land and buildings
Property, plant and equipment
As of the beginning of period	41,486,215	34,698,618
Additions		57,252
Transfers	168,569
Foreign currency translation	4,099,357	118,430
Revaluation	4,482,496	189,731
As of the end of period	41,271,645	34,684,569
Gross carrying amount | Buildings in progress
Property, plant and equipment
As of the beginning of period	1,995,265	1,270,539
Additions	551,106	451,324
Transfers	(593,483)
Disposals	(127,338)
Foreign currency translation	237,750	(4,188)
As of the end of period	$ 2,063,300	$ 1,717,675

INFORMATION ABOUT COMPONENTS_14

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - accumulated depreciation (Details) - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Property, plant and equipment
As of the beginning of period	$ 47,954,596
As of the end of period	48,946,555
Office equipment
Property, plant and equipment
As of the beginning of period	288,920
As of the end of period	244,773
Vehicles
Property, plant and equipment
As of the beginning of period	1,835,634
As of the end of period	2,387,064
Equipment and computer software
Property, plant and equipment
As of the beginning of period	67,105
As of the end of period	142,803
Fixture and fittings
Property, plant and equipment
As of the beginning of period	2,967,431
As of the end of period	3,501,808
Machinery and equipment
Property, plant and equipment
As of the beginning of period	5,125,728
As of the end of period	5,493,935
Land and buildings
Property, plant and equipment
As of the beginning of period	35,674,513
As of the end of period	35,112,872
Accumulated depreciation/amortization
Property, plant and equipment
As of the beginning of period	(16,019,806)	$ (13,012,286)
Disposals	251,108	120,049
Depreciation of the period	(1,668,788)	(1,104,537)
Foreign currency translation	(1,695,110)	(33,186)
Revaluation	(692,630)	(48,917)
As of the end of period	(18,439,966)	(13,981,043)
Accumulated depreciation/amortization | Office equipment
Property, plant and equipment
As of the beginning of period	(473,905)	(391,602)
Disposals		2,964
Depreciation of the period	(23,583)	(19,750)
Foreign currency translation	(51,063)	(702)
As of the end of period	(548,551)	(409,090)
Accumulated depreciation/amortization | Vehicles
Property, plant and equipment
As of the beginning of period	(1,676,583)	(1,828,087)
Disposals	196,985	117,085
Depreciation of the period	(413,229)	(289,400)
Foreign currency translation	(43,972)	2,031
As of the end of period	(1,936,799)	(1,998,371)
Accumulated depreciation/amortization | Equipment and computer software
Property, plant and equipment
As of the beginning of period	(525,021)	(433,231)
Disposals	49,631
Depreciation of the period	(48,637)	(20,737)
Foreign currency translation	(31,979)	(1,315)
As of the end of period	(556,006)	(455,283)
Accumulated depreciation/amortization | Fixture and fittings
Property, plant and equipment
As of the beginning of period	(2,670,512)	(1,801,356)
Depreciation of the period	(327,792)	(169,806)
Foreign currency translation	(315,287)	(5,607)
As of the end of period	(3,313,591)	(1,976,769)
Accumulated depreciation/amortization | Machinery and equipment
Property, plant and equipment
As of the beginning of period	(4,862,083)	(3,605,468)
Disposals	4,492
Depreciation of the period	(516,171)	(291,265)
Foreign currency translation	(552,484)	(11,406)
As of the end of period	(5,926,246)	(3,908,139)
Accumulated depreciation/amortization | Land and buildings
Property, plant and equipment
As of the beginning of period	(5,811,702)	(4,952,542)
Depreciation of the period	(339,376)	(313,579)
Foreign currency translation	(700,325)	(16,187)
Revaluation	(692,630)	(48,917)
As of the end of period	$ (6,158,773)	$ (5,233,391)

INFORMATION ABOUT COMPONENTS_15

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020	Jun. 30, 2020
Intangible assets
Intangible assets	$ 72,563,018	$ 67,342,362
Gross carrying amount
Intangible assets
Intangible assets	85,908,018	78,019,203	$ 66,376,939	$ 42,832,837
Accumulated depreciation/amortization
Intangible assets
Intangible assets	$ (13,345,000)	$ (10,676,841)	$ (8,595,456)	$ (7,499,373)

INFORMATION ABOUT COMPONENTS_16

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, net carrying amount (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Intangible assets
Intangible assets	$ 72,563,018	$ 67,342,362
Soybean HB4 and breeding program
Intangible assets
Intangible assets	29,451,462	27,611,142
Ecoseed integrated products
Intangible assets
Intangible assets	2,848,985	2,558,220
Microbiology product
Intangible assets
Intangible assets	4,721,078	3,996,657
Trademarks and patents
Intangible assets
Intangible assets	7,330,948	6,923,256
Software
Intangible assets
Intangible assets	2,261,197	1,849,041
Customer loyalty
Intangible assets
Intangible assets	20,949,348	19,404,046
RG/RS/OX Wheat
Intangible assets
Intangible assets	$ 5,000,000	$ 5,000,000

INFORMATION ABOUT COMPONENTS_17

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, gross carrying amount (Details) - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Intangible assets
Balance at beginning of the period	$ 67,342,362
Balance at end of the period	72,563,018
Gross carrying amount
Intangible assets
Balance at beginning of the period	78,019,203	$ 42,832,837
Additions		23,420,130
Additions	2,771,512
Foreign currency translation	5,117,303	123,972
Balance at end of the period	85,908,018	66,376,939
Soybean HB4 and breeding program
Intangible assets
Balance at beginning of the period	27,611,142
Balance at end of the period	29,451,462
Soybean HB4 and breeding program | Gross carrying amount
Intangible assets
Balance at beginning of the period	27,611,142	7,345,923
Additions		19,063,357
Additions	1,840,320
Transfers		186,804
Foreign currency translation		609
Balance at end of the period	29,451,462	26,223,085
Soybean HB4 and breeding program | Verdeca LLC
Intangible assets
Additions		18,400,000
Ecoseed integrated products
Intangible assets
Balance at beginning of the period	2,558,220
Balance at end of the period	2,848,985
Ecoseed integrated products | Gross carrying amount
Intangible assets
Balance at beginning of the period	2,558,220	2,296,955
Foreign currency translation	290,765	7,537
Balance at end of the period	2,848,985	2,304,492
Microbiology product
Intangible assets
Balance at beginning of the period	3,996,657
Balance at end of the period	4,721,078
Microbiology product | Gross carrying amount
Intangible assets
Balance at beginning of the period	6,037,680	3,867,593
Additions		922,937
Additions	584,924
Foreign currency translation	648,526	21,369
Balance at end of the period	7,271,130	4,811,899
Trademarks and patents
Intangible assets
Balance at beginning of the period	6,923,256
Balance at end of the period	7,330,948
Trademarks and patents | Gross carrying amount
Intangible assets
Balance at beginning of the period	9,824,171	8,432,746
Foreign currency translation	1,129,486	27,672
Balance at end of the period	10,953,657	8,460,418
Software
Intangible assets
Balance at beginning of the period	1,849,041
Balance at end of the period	2,261,197
Software | Gross carrying amount
Intangible assets
Balance at beginning of the period	3,784,593	2,088,929
Additions		502,137
Additions	346,268
Transfers		186,804
Foreign currency translation	508,279	5,092
Balance at end of the period	4,639,140	2,782,962
Customer loyalty
Intangible assets
Balance at beginning of the period	19,404,046
Balance at end of the period	20,949,348
Customer loyalty | Gross carrying amount
Intangible assets
Balance at beginning of the period	23,203,397	18,800,691
Foreign currency translation	2,540,247	61,693
Balance at end of the period	25,743,644	18,862,384
GLA/ARA safflower | Gross carrying amount
Intangible assets
Additions		2,931,699
Balance at end of the period		$ 2,931,699
RG/RS/OX Wheat
Intangible assets
Balance at beginning of the period	5,000,000
Balance at end of the period	5,000,000
RG/RS/OX Wheat | Gross carrying amount
Intangible assets
Balance at beginning of the period	5,000,000
Balance at end of the period	$ 5,000,000

INFORMATION ABOUT COMPONENTS_18

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, accumulated amortization (Details) - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Intangible assets
Balance at beginning of the period	$ 67,342,362
Balance at end of the period	72,563,018
Accumulated depreciation/amortization
Intangible assets
Balance at beginning of the period	(10,676,841)	$ (7,499,373)
Amortization of the period	(1,375,998)	(1,071,448)
Foreign currency translation	(1,292,161)	(24,635)
Balance at end of the period	(13,345,000)	(8,595,456)
Microbiology product
Intangible assets
Balance at beginning of the period	3,996,657
Balance at end of the period	4,721,078
Microbiology product | Accumulated depreciation/amortization
Intangible assets
Balance at beginning of the period	(2,041,023)	(1,363,962)
Amortization of the period	(259,522)	(229,417)
Foreign currency translation	(249,507)	(5,407)
Balance at end of the period	(2,550,052)	(1,598,786)
Trademarks and patents
Intangible assets
Balance at beginning of the period	6,923,256
Balance at end of the period	7,330,948
Trademarks and patents | Accumulated depreciation/amortization
Intangible assets
Balance at beginning of the period	(2,900,915)	(2,057,964)
Amortization of the period	(368,581)	(279,016)
Foreign currency translation	(353,213)	(6,754)
Balance at end of the period	(3,622,709)	(2,343,734)
Software
Intangible assets
Balance at beginning of the period	1,849,041
Balance at end of the period	2,261,197
Software | Accumulated depreciation/amortization
Intangible assets
Balance at beginning of the period	(1,935,552)	(1,401,964)
Amortization of the period	(212,148)	(200,277)
Foreign currency translation	(230,243)	(3,695)
Balance at end of the period	(2,377,943)	(1,605,936)
Customer loyalty
Intangible assets
Balance at beginning of the period	19,404,046
Balance at end of the period	20,949,348
Customer loyalty | Accumulated depreciation/amortization
Intangible assets
Balance at beginning of the period	(3,799,351)	(2,675,483)
Amortization of the period	(535,747)	(362,738)
Foreign currency translation	(459,198)	(8,779)
Balance at end of the period	$ (4,794,296)	$ (3,047,000)

INFORMATION ABOUT COMPONENTS_19

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Goodwill
Goodwill	$ 32,288,120	$ 28,751,206
Rizobacter Argentina S.A.
Goodwill
Goodwill	25,080,278	22,277,336
Bioceres Crops S.A.
Goodwill
Goodwill	6,737,752	6,003,780
Insumos Agroqumicos S.A.
Goodwill
Goodwill	$ 470,090	$ 470,090

INFORMATION ABOUT COMPONENTS_20

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payable (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Current
Trade creditors	$ 82,253,229	$ 51,389,515
Taxes	2,138,995	2,556,945
Miscellaneous	273,704	229,339
Trade and other payable	106,016,242	72,091,408
Shareholders and other other related parties
Current
Trade payable, related party	53,661	52,864
Parent company
Current
Trade payable, related party	182,812	193,718
Joint ventures and associates
Current
Trade payable, related party	$ 21,113,841	$ 17,669,027

INFORMATION ABOUT COMPONENTS_21

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details) - USD ($)	Dec. 31, 2021	Dec. 23, 2021	Jun. 30, 2021
Current
Corporate bonds	$ 5,358,525		$ 24,742,752
Borrowings	48,230,663		76,785,857
Non-current
Corporate bonds	74,004,867		37,826,641
Borrowings	90,738,228		47,988,468
Bank overdraft
Current
Borrowings			32,838
Bank borrowings
Current
Borrowings	36,004,973		33,684,287
Non-current
Borrowings	8,656,385		4,161,827
Corporate bonds
Non-current
Notional amount		$ 20,000,000
Nominal annual rate		1.49%
Trust debt securities
Current
Borrowings	3,080,286		3,470,448
Non-current
Borrowings	2,076,976
Other finance debt
Current
Borrowings	89,164
Subordinated loan
Current
Borrowings			11,276,611
Parents companies and related parties
Current
Borrowings	3,697,715		3,578,921
Non-current
Borrowings	$ 6,000,000		$ 6,000,000

INFORMATION ABOUT COMPONENTS_22

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Current
Borrowings	$ 48,230,663	$ 76,785,857
Corporate bonds	5,358,525	24,742,752
Non-current
Borrowings	90,738,228	47,988,468
Corporate bonds	74,004,867	37,826,641
Amortized cost
Current
Corporate bonds	5,358,525	24,742,752
Non-current
Corporate bonds	74,004,867	37,826,641
Fair value
Current
Corporate bonds	5,322,676	24,085,087
Non-current
Corporate bonds	68,109,433	32,656,097
Bank borrowings
Current
Borrowings	36,004,973	33,684,287
Non-current
Borrowings	8,656,385	4,161,827
Bank borrowings | Amortized cost
Current
Borrowings	36,004,973	33,684,287
Non-current
Borrowings	8,656,385	4,161,827
Bank borrowings | Fair value
Current
Borrowings	34,440,750	32,770,615
Non-current
Borrowings	$ 7,985,438	$ 3,864,666

INFORMATION ABOUT COMPONENTS_23

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
Salaries, accrued incentives, vacations and social security	$ 6,201,169	$ 4,243,585
Key management personnel	270,909	436,493
Employee benefits and social security	$ 6,472,078	$ 4,680,078

INFORMATION ABOUT COMPONENTS_24

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - Revenue (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Revenue
Royalties			$ 1,129,024	$ 1,492,026
Revenues from contracts with customers	$ 92,313,776	$ 48,003,308	158,667,650	90,108,598
Sale of goods and services
Revenue
Revenues from contracts with customers			$ 157,538,626	$ 88,616,572

INFORMATION ABOUT COMPONENTS_25

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - Cost of Sales (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
Inventories as of the beginning of the period			$ 39,052,925	$ 29,338,548
Purchases of the period			102,342,174	56,271,944
Production costs			7,581,570	5,514,975
Foreign currency translation			516,306	(1,283,574)
Subtotal			149,492,975	89,841,893
Inventories as of the end of the period	$ 56,277,533	$ 41,655,409	56,277,533	41,655,409
Cost of sales	$ 55,332,989	$ 25,073,842	$ 93,215,442	$ 48,186,484

INFORMATION ABOUT COMPONENTS_26

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - R&D classified by nature (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
R&D classified by nature
Depreciation of leased assets			$ 501,232	$ 287,484
Research and development expenses	$ 1,384,032	$ 1,114,820	2,815,574	2,139,032
R&D capitalized			2,425,244	1,556,367
R&D profit and loss	$ 1,384,032	$ 1,114,820	2,815,574	2,139,032
Total			5,240,818	3,695,399
Research and development expenses
R&D classified by nature
Amortization of intangible assets			604,462	508,433
Import and export expenses			1,685	9,322
Depreciation of property, plant and equipment			213,837	69,860
Employee benefits and social securities			685,412	496,967
Maintenance			25,702	14,045
Energy and fuel			24,659	17,564
Supplies and materials			726,899	460,272
Mobility and travel			38,564	4,668
Share-based incentives			30,099
Professional fees and outsourced services			137,674	67,550
Professional fees related parties			296,967	466,144
Office supplies			2,842	2,467
Information technology expenses			6,039	9,992
Insurance			12,598	8,326
Depreciation of leased assets			2,523	1,279
Miscellaneous			5,612	2,143
Research and development expenses			2,815,574	2,139,032
R&D profit and loss			$ 2,815,574	$ 2,139,032

INFORMATION ABOUT COMPONENTS_27

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - Expenses classified by nature and function (Details) - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Production costs and selling, general and administrative expenses
Impairment of receivables	$ 815,929	$ 126,593
Obsolescence	740,264	365,458
Production costs
Production costs and selling, general and administrative expenses
Analysis and Storage	26,537	18,651
Commissions and Royalties	547,364	767,326
Import and Export Expenses	61,209	29,128
Depreciation of property, plant and equipment	655,067	560,806
Depreciation of leased assets	246,942	125,226
Freight and haulage	311,416	248,785
Employee benefits and social securities	3,265,750	2,260,596
Maintenance	400,778	282,937
Energy and fuel	233,958	156,666
Supplies and Materials	351,410	187,315
Mobility and travel	7,361	1,593
Professional fees and outsourced services	587,370	335,681
Office supplies	89,670	89,049
Insurance	36,328	68,033
Information technology expenses		849
Obsolescence	740,264	365,458
Taxes	19,398	16,609
Miscellaneous	748	267
Total	7,581,570	5,514,975
Selling, general and administrative expenses
Production costs and selling, general and administrative expenses
Amortization of intangible assets	771,536	563,015
Analysis and Storage	69,502	46,251
Commissions and Royalties	1,181,465	287,445
Import and Export Expenses	560,934	434,113
Depreciation of property, plant and equipment	799,884	473,871
Depreciation of leased assets	251,767	160,979
Impairment of receivables	815,929	126,593
Freight and haulage	4,457,096	2,023,017
Employee benefits and social securities	11,033,554	7,010,150
Maintenance	570,294	259,182
Energy and fuel	24,908	23,848
Supplies and Materials	570,762	58,212
Mobility and travel	696,370	369,382
Publicity and advertising	2,247,729	1,062,884
Contingencies.	65,598	52,441
Stock options-based incentives	843,308	636,519
Professional fees and outsourced services	3,075,667	4,040,404
Professional fees related parties	48,934	113,888
Office supplies	198,228	150,121
Insurance	556,441	392,752
Information technology expenses	817,032	530,970
Taxes	5,230,416	2,431,415
Miscellaneous	110,407	64,507
Total	34,997,761	21,311,959
Total
Production costs and selling, general and administrative expenses
Amortization of intangible assets	771,536	563,015
Analysis and Storage	96,039	64,902
Commissions and Royalties	1,728,829	1,054,771
Import and Export Expenses	622,143	463,241
Depreciation of property, plant and equipment	1,454,951	1,034,677
Depreciation of leased assets	498,709	286,205
Impairment of receivables	815,929	126,593
Freight and haulage	4,768,512	2,271,802
Employee benefits and social securities	14,299,304	9,270,746
Maintenance	971,072	542,119
Energy and fuel	258,866	180,514
Supplies and Materials	922,172	245,527
Mobility and travel	703,731	370,975
Publicity and advertising	2,247,729	1,062,884
Contingencies.	65,598	52,441
Stock options-based incentives	843,308	636,519
Professional fees and outsourced services	3,663,037	4,376,085
Professional fees related parties	48,934	113,888
Office supplies	287,898	239,170
Insurance	592,769	460,785
Information technology expenses	817,032	531,819
Obsolescence	740,264	365,458
Taxes	5,249,814	2,448,024
Miscellaneous	111,155	64,774
Total	$ 42,579,331	$ 26,826,934

INFORMATION ABOUT COMPONENTS_28

INFORMATION ABOUT COMPONENTS OF UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - Finance results (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Financial costs
Interests expenses with the Parents			$ (415,812)	$ (634,128)
Interests expenses			(5,439,593)	(9,043,815)
Financial commissions			(907,660)	(964,237)
Financial Costs	$ (3,420,256)	$ (5,366,130)	(6,763,065)	(10,642,180)
Other finance results
Exchange differences generated by assets			6,355,520	10,714,855
Exchange differences generated by liabilities			(11,682,895)	(16,991,043)
Changes in fair value of financial assets or liabilities and other financial results			(1,652,984)	(5,466,867)
Net gain of inflation effect on monetary items			342,135	3,752,899
Other finance results	$ (4,801,365)	$ (530,744)	(6,638,224)	(7,990,156)
Total net financial results			$ (13,401,289)	$ (18,632,336)

TAXATION - Taxes on income (Det

TAXATION - Taxes on income (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
TAXATION
Current tax expense			$ 11,916,178	$ 6,716,736
Deferred tax			(5,179,763)	(875,283)
Income tax expenses	$ (4,141,102)	$ (3,835,587)	$ (6,736,415)	$ (5,841,453)

TAXATION - Movement on the defe

TAXATION - Movement on the deferred income tax (Details) - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
TAXATION
Beginning of the period deferred tax	$ (22,421,125)	$ (14,164,930)
Charge of the period	5,179,763	875,283
Charge to OCI	1,326,453	35,204
Conversion difference	(2,993,421)	(145,175)
Total net deferred tax	$ (18,908,330)	$ (13,399,618)

TAXATION - Reconciliation of th

TAXATION - Reconciliation of the statutory tax rate (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
TAXATION
Earning before income tax-rate			$ 14,340,137	$ 1,270,149
Income tax expense by applying tax rate in force in the respective countries			(7,314,555)	(4,007,409)
Share of profit or loss of subsidies, joint ventures and associates			269,138	100,552
Stock options charge			(180,523)	(29,199)
Rate change adjustment				(163,269)
Non-deductible expenses			315,241	295,416
Representation expenses			(3,039)	(10,972)
Foreign investment coverage			140,720	248,743
Tax Inflation Adjustment			1,097,315	(1,197,624)
Result of inflation effect on monetary items and other finance results			(479,093)	(457,537)
Others			48,863	(29,322)
Income tax expenses	$ (4,141,102)	$ (3,835,587)	$ (6,736,415)	$ (5,841,453)

EARNINGS PER SHARE (EPS) (Detai

EARNINGS PER SHARE (EPS) (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Numerator
Profit (loss) for the period (basic EPS)	$ 3,427,093	$ 648,193	$ 4,301,230	$ (6,323,365)
Profit (loss) for the period (diluted EPS)	$ 3,427,093	$ 648,193	$ 4,301,230	$ (6,323,365)
Denominator
Weighted average number of shares (basic EPS)	41,104,331	38,016,601	41,104,331	38,016,601
Weighted average number of shares (diluted EPS)	42,403,196	39,038,280	42,403,196	38,016,601
Basic profit (loss) attributable to ordinary equity holders of the parent	$ 0.0834	$ 0.0171	$ 0.1046	$ (0.1663)
Diluted profit (loss) attributable to ordinary equity holders of the parent	$ 0.0808	$ 0.0166	$ 0.1014	$ (0.1663)

INFORMATION ABOUT UNAUDITED I_2

INFORMATION ABOUT UNAUDITED INTERIM CONDENSED CONSOLIDATED COMPONENTS OF EQUITY - Share capital (Details)	6 Months Ended
	Dec. 31, 2021USD ($)Vote$ / sharesshares	Aug. 02, 2021USD ($)shares
Disclosure of classes of share capital [line items]
Number of votes for each ordinary share | Vote	1
Principal amount of convertible notes | $	$ 49,100,000
Major business combination [member] | Insuagro [Member]
Disclosure of classes of share capital [line items]
Number of shares acquired		2,467,990
Adjusted EBITDA Per Share Multiple	3.5
Consideration of payment | $		$ 700,000
Number of shares owned	13,489,990
Percentage of equity interests acquired	61.32%
Percentage of voting interests acquired	61.22%
Equity Compensation Plan [Member]
Disclosure of classes of share capital [line items]
Share options granted under share option agreements | $	2,031,058
Ordinary shares [member]
Disclosure of classes of share capital [line items]
Number of shares authorised	100,000,000
Par value per share | $ / shares	$ 0.0001
Number of shares issued	41,105,321
Number of shares outstanding	41,105,321
Preference shares [member]
Disclosure of classes of share capital [line items]
Number of shares authorised	1,000,000
Par value per share | $ / shares	$ 0.0001
Number of shares issued	0
Number of shares outstanding	0

CASH FLOW INFORMATION (Details)

CASH FLOW INFORMATION (Details) - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Investment activities
Settlement of receivables through PPE contribution		$ 1,547,543
Investment in kind in other related parties (Note 15)	$ 437,780	921,390
Acquisition of assets financed by debt		7,637,972
Acquisition of assets through issuance of capital		15,000,000
Investing activities	437,780	$ 25,106,905
Financing activities
Acquisition of non-controlling interest in subsidiaries	255,893
Financing activities	$ 255,893

JOINT VENTURES AND ASSOCIATES_2

JOINT VENTURES AND ASSOCIATES (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2021
JOINT VENTURES
Assets in joint ventures and associates	$ 34,054,957		$ 34,054,957		$ 30,657,173
Liabilities in joint ventures and associates	616,173		616,173		1,278,250
Share of profit or loss of joint ventures and affiliates	1,141,323	$ 65,975	919,087	$ 305,687
Trigall Genetics S.A.
JOINT VENTURES
Liabilities in joint ventures and associates	616,173		616,173		1,278,250
Share of profit or loss of joint ventures and affiliates			662,077	(98,280)
Synertech Industrias S.A.
JOINT VENTURES
Assets in joint ventures and associates	30,867,914		30,867,914		27,572,597
Share of profit or loss of joint ventures and affiliates			319,356	376,635
Indrasa Biotecnologia S.A.
JOINT VENTURES
Assets in joint ventures and associates	113,821		113,821		54,957
Share of profit or loss of joint ventures and affiliates			52,363	$ 27,332
Alfalfa Technologies S.R.L
JOINT VENTURES
Assets in joint ventures and associates	91,240		91,240		97,920
Moolec Science Limited
JOINT VENTURES
Assets in joint ventures and associates	$ 2,981,982		2,981,982		$ 2,931,699
Share of profit or loss of joint ventures and affiliates			$ (114,709)

JOINT VENTURES AND ASSOCIATES -

JOINT VENTURES AND ASSOCIATES - Changes in joint ventures investments (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
JOINT VENTURES AND ASSOCIATES
As of the beginning of the period			$ 29,378,923	$ 23,103,963
Revaluation of property, plant and equipment	$ (189,996)	$ (25,630)	(363,848)	(11,495)
Foreign currency translation	1,887,130	126,434	3,504,622	49,996
Share of profit or loss	1,141,323	65,975	919,087	305,687
As of the end of the period	$ 33,438,784	$ 23,448,151	$ 33,438,784	$ 23,448,151

SEGMENT INFORMATION - Group's r

SEGMENT INFORMATION - Group's reporting segments (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Revenues
Sale of goods and services	$ 92,313,776	$ 48,003,308	$ 158,667,650	$ 90,108,598
Royalties			1,129,024	1,492,026
Government grants	337	556	805	1,160
Initial recognition and changes in the fair value of biological assets	1,590,925	734,826	2,142,828	984,193
Changes in the net realizable value of agricultural products after harvest	(1,242,185)		(1,242,185)
Total	92,662,853	48,738,690	159,569,098	91,093,951
Cost of sales	$ (55,332,989)	$ (25,073,842)	(93,215,442)	(48,186,484)
Gross profit per segment			$ 66,353,656	$ 42,907,467
% Gross margin			42.00%	47.00%
Seed and integrated products
Revenues
Royalties			$ 1,129,024	$ 1,492,026
Government grants			805	1,160
Initial recognition and changes in the fair value of biological assets			1,033,753	470,789
Changes in the net realizable value of agricultural products after harvest			(821,078)
Total			25,110,137	21,155,651
Cost of sales			(8,988,420)	(8,705,712)
Gross profit per segment			$ 16,121,717	$ 12,449,939
% Gross margin			64.00%	59.00%
Crop protection
Revenues
Initial recognition and changes in the fair value of biological assets			$ 845,387	$ 119,039
Changes in the net realizable value of agricultural products after harvest			(304,522)
Total			82,603,469	48,696,101
Cost of sales			(57,480,257)	(28,703,147)
Gross profit per segment			$ 25,123,212	$ 19,992,954
% Gross margin			30.00%	41.00%
Crop nutrition
Revenues
Initial recognition and changes in the fair value of biological assets			$ 263,688	$ 394,365
Changes in the net realizable value of agricultural products after harvest			(116,585)
Total			51,855,492	21,242,199
Cost of sales			(26,746,765)	(10,777,625)
Gross profit per segment			$ 25,108,727	$ 10,464,574
% Gross margin			48.00%	49.00%
Sale of goods and services
Revenues
Sale of goods and services			$ 157,538,626	$ 88,616,572
Sale of goods and services | Seed and integrated products
Revenues
Sale of goods and services			23,767,633	19,191,676
Sale of goods and services | Crop protection
Revenues
Sale of goods and services			82,062,604	48,577,062
Sale of goods and services | Crop nutrition
Revenues
Sale of goods and services			$ 51,708,389	$ 20,847,834

FINANCIAL INSTRUMENTS - RISK _3

FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial assets by category (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Amortized cost
Financial assets by category
Financial assets.	$ 161,320,430	$ 123,776,201
Fair value
Financial assets by category
Financial assets.	3,761,667	18,453,966
Cash and cash equivalents | Amortized cost
Financial assets by category
Financial assets.	35,966,810	28,327,569
Cash and cash equivalents | Fair value
Financial assets by category
Financial assets.	399,321	7,718,544
Other financial assets | Amortized cost
Financial assets by category
Financial assets.	1,114,325	1,523,438
Other financial assets | Fair value
Financial assets by category
Financial assets.	3,362,346	10,735,422
Trade receivables | Amortized cost
Financial assets by category
Financial assets.	119,406,290	88,919,911
Other receivables | Amortized cost
Financial assets by category
Financial assets.	$ 4,833,005	$ 5,005,283

FINANCIAL INSTRUMENTS - RISK _4

FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial liabilities by category (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Amortized cost
Financial liabilities by category
Financial liabilities	$ 313,907,195	$ 263,141,073
Fair value
Financial liabilities by category
Financial liabilities	89,164
Trade and other payables | Amortized cost
Financial liabilities by category
Financial liabilities	106,016,242	72,091,408
Borrowings | Amortized cost
Financial liabilities by category
Financial liabilities	138,879,727	124,774,325
Borrowings | Fair value
Financial liabilities by category
Financial liabilities	89,164
Convertible notes | Amortized cost
Financial liabilities by category
Financial liabilities	48,890,332	48,664,012
Lease liability | Amortized cost
Financial liabilities by category
Financial liabilities	1,205,745	1,140,717
Employee benefits and social security | Amortized cost
Financial liabilities by category
Financial liabilities	6,472,078	4,680,078
Consideration for acquisition of assets | Amortized cost
Financial liabilities by category
Financial liabilities	$ 12,443,071	$ 11,790,533

FINANCIAL INSTRUMENTS - RISK _5

FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Fair value by hierarchy (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Mutual funds | Level 1
Fair value by hierarchy
Financial assets at fair value	$ 399,321	$ 7,718,544
Other Investment | Level 1
Fair value by hierarchy
Financial assets at fair value	1,476,793	2,110,414
Other Investment | Level 2
Fair value by hierarchy
Financial assets at fair value		739,071
US Treasury bills | Level 1
Fair value by hierarchy
Financial assets at fair value	1,885,553	$ 7,885,937
Other Finance debt | Level 2
Fair value by hierarchy
Financial liabilities, at fair value	$ 89,164

SHAREHOLDERS AND OTHER RELATE_3

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Transactions (Details) - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Trade and other payable
In-kind contributions	$ 437,780	$ 921,390
Total	(21,970,862)	(9,103,708)
Joint ventures
Trade and other payable
Sales of goods and services	10,839,406	2,920,262
Purchases of goods and services	(29,026,646)	(9,763,160)
Net loans granted		18,409
Key management personnel
Trade and other payable
Salaries, social security benefits and other benefits	(1,677,312)	(1,716,413)
Net loans cancelled		(603,093)
Interest gain		(8,879)
Shareholders and other other related parties
Trade and other payable
Sales of goods and services	313,432	161,792
Purchases of goods and services	(2,441,710)	(399,888)
In-kind contributions	437,780	921,390
Parent company
Trade and other payable
Interest gain	$ (415,812)	$ (634,128)

SHAREHOLDERS AND OTHER RELATE_4

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Receivable (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Trade and other payable
Other receivables	$ 16,255,750	$ 11,153,705
Total	4,995,144	3,345,632
Parent company
Trade and other payable
Other receivables		770,549
Parent companies and related parties to Parent
Trade and other payable
Other receivables		770,549
Shareholders and other other related parties
Trade and other payable
Trade receivables	444,095
Other receivables - Other related parties
Trade and other payable
Other receivables	129,167	134,172
Joint ventures
Trade and other payable
Trade receivables	1,741,964	221,048
Other receivables	$ 2,679,918	$ 2,219,863

SHAREHOLDERS AND OTHER RELATE_5

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Payables (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2021
Trade and other payable
Borrowings	$ (48,230,663)	$ (76,785,857)
Total	31,318,938	27,931,023
Parent company
Trade and other payable
Trade payables	(182,812)	(193,718)
Parent companies and related parties to Parent
Trade and other payable
Trade payables	(182,812)	(193,718)
Loans payables	(9,697,715)	(9,578,921)
Key management personnel
Trade and other payable
Salaries, social security benefits and other benefits	(270,909)	(436,493)
Shareholders and other other related parties
Trade and other payable
Trade payables	(53,661)	(52,864)
Joint ventures
Trade and other payable
Trade payables	$ (21,113,841)	$ (17,669,027)

KEY MANAGEMENT PERSONNEL COMP_3

KEY MANAGEMENT PERSONNEL COMPENSATION - Summary of compensation of directors and other members (Details) - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
KEY MANAGEMENT PERSONNEL COMPENSATION
Salaries, social security and other benefits	$ 803,905	$ 1,079,894
Share-based incentives	873,407	636,519
Total	$ 1,677,312	$ 1,716,413

SHARE-BASED PAYMENTS - Options

SHARE-BASED PAYMENTS - Options (Details)	6 Months Ended
	Dec. 31, 2021USD ($)$ / sharesshares	Dec. 31, 2020USD ($)
SHARE-BASED PAYMENTS
Period to date to date exercise price of options on cashless basis at their WVAP	20 days
Options incentive Plan
SHARE-BASED PAYMENTS
Number of options, granted during the period | $	93,600	0
Directors and Sr, Management
SHARE-BASED PAYMENTS
Number of shares authorized to be granted | shares	1,200,000
Exercise price, share options granted | $ / shares	$ 4.55
Junior Management
SHARE-BASED PAYMENTS
Number of shares authorized to be granted | shares	100,000
Exercise price, share options granted | $ / shares	$ 5.55

SHARE-BASED PAYMENTS - Fair val

SHARE-BASED PAYMENTS - Fair value of share options (Details)	6 Months Ended
	Dec. 31, 2021USD ($)Y$ / shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Estimates of options that will be exercised (as a percent)	100.00%
Directors and Sr, Management
Disclosure of terms and conditions of share-based payment arrangement [line items]
Weighted average fair value of shares (per option))	$ 5.42
Exercise price	$ 4.55
Expected volatility	29.69%
Expected dividend rate	0.00%
Risk-free interest rate	1.66%
Weighted average expected life of stock options | $	9.89
Weighted average fair value at measurement date (per option) | $	$ 2.47
Junior Management
Disclosure of terms and conditions of share-based payment arrangement [line items]
Weighted average fair value of shares (per option))	$ 13.98
Exercise price	$ 5.55
Expected volatility	42.18%
Expected dividend rate	0.00%
Risk-free interest rate	1.17%
Weighted average expected life of stock options | Y	9.22
Weighted average fair value at measurement date (per option) | $	$ 10.1

SHARE-BASED PAYMENTS - Option a

SHARE-BASED PAYMENTS - Option activity (Details) - Options incentive Plan	6 Months Ended
	Dec. 31, 2021USD ($)$ / shares	Dec. 31, 2020USD ($)$ / shares
SHARE-BASED PAYMENTS
Number of options, at the beginning	1,166,667	1,200,000
Number of options, granted during the period	93,600	0
Number of shares, exercised during the period	(2,000)
Number of options, effective at year/period end	1,258,267	1,200,000
Weighted average exercise price, at the beginning | $ / shares	$ 4.55	$ 4.55
Weighted average exercise price, granted during the year/period | $ / shares	5.55	0
Weighted average exercise price, exercised during the period | $ / shares	5.55
Weighted average exercise price, effective at period end | $ / shares	$ 4.62	$ 4.55
Charge of the plan recognized	$ 600,000

SHARE-BASED PAYMENTS - Annual c

SHARE-BASED PAYMENTS - Annual compensation - Bonus (Details) $ in Thousands	6 Months Ended
	Dec. 31, 2021USD ($)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Charge in consideration of the annual compensation bonus for objectives achieved	$ 100
Number of days VWAP considered for bonus payment	20 days
Bonus in Kind
Disclosure of terms and conditions of share-based payment arrangement [line items]
Charge in consideration of the annual compensation bonus for objectives achieved	$ 150
Bonus in Kind | Vests immediately
Disclosure of terms and conditions of share-based payment arrangement [line items]
Bonus vesting percentage	50.00%
Bonus in Kind | Vests in the subsequent 12-months
Disclosure of terms and conditions of share-based payment arrangement [line items]
Bonus vesting percentage	50.00%

LEASE - Right-of-use lease asse

LEASE - Right-of-use lease asset (Details) - USD ($)	6 Months Ended		12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2021
Right-of-use leased asset
Book value at the beginning of the period	$ 1,327,660
Depreciation of the period	501,232	$ 287,484
End of the period	1,488,608		$ 1,327,660
Gross carrying amount
Right-of-use leased asset
Book value at the beginning of the period	3,688,150	2,369,326	2,369,326
Additions of the period	612,579		913,321
Exchange differences	(156,673)		405,503
End of the period	4,144,056		3,688,150
Accumulated depreciation/amortization
Right-of-use leased asset
Book value at the beginning of the period	(2,360,490)	$ (1,254,729)	(1,254,729)
Exchange differences	(206,274)		278,441
Depreciation of the period	501,232		827,320
End of the period	$ (2,655,448)		$ (2,360,490)

LEASE - Liabilities roll forwar

LEASE - Liabilities roll forward (Details) - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2021	Jun. 30, 2021
Disclosure of initial application of standards or interpretations [line items]
Book value at the beginning of the period	$ 1,140,717	$ 1,109,812
Additions of the period	396,205	259,427
Interest expenses, exchange differences and inflation effects	162,276	500,442
Payment of the period	(493,453)	(728,964)
Total	1,205,745	1,140,717
Lease Liabilities
Non-current	570,505	390,409
Current	635,240	750,308
Total	$ 1,205,745	$ 1,140,717

LEASE - Right-of-use lease as_2

LEASE - Right-of-use lease asset by type (Details) - USD ($)	6 Months Ended
	Dec. 31, 2021	Jun. 30, 2021	Jun. 30, 2020
Right-of-use leased asset
Right of use asset	$ 1,488,608	$ 1,327,660
Incremental borrowing rate	3.52%
Gross carrying amount
Right-of-use leased asset
Right of use asset	$ 4,144,056	3,688,150	$ 2,369,326
Gross carrying amount | Machinery and equipment
Right-of-use leased asset
Right of use asset	742,417	661,544
Gross carrying amount | Vehicles
Right-of-use leased asset
Right of use asset	1,007,824	1,061,184
Gross carrying amount | Equipment and computer software
Right-of-use leased asset
Right of use asset	668,160	582,101
Gross carrying amount | Land and buildings
Right-of-use leased asset
Right of use asset	$ 1,725,655	$ 1,383,321